







This report presents total prevalence
estimates for selected eye conditions,
decrease in vision from eye pathology, and
related need for medical care among the
U.S. population ages 1-74 years by age,
race, sex, and selected demographic
characteristics. These estimates are based
on standardized eye examination findings
from the national probability sample of the
civilian noninstitutionalized population
examined in the first National Health and
Nutrition Examination Survey, 1971-72.
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by James P. Ganley, M.D., Dr.P.H., Louisiana State
University Medical Center, Shreveport, La., and Jean
Roberts, M.S., Division of Health Examination
Statistics
Introduction Statistics are based on findings from the standardizedophthahnology examination given the national proba-
This report contains estimates of the total prova- bility sample of persons examined in the National
lence of the various types of eye abnormalities, the Health and Nutrition Examination Survey of 1971–72.
need for related medical care, and vision decrease from The findings from this cross-sectional study are ana-
such pathology among the civilian noninstitutionalized lyzed with respect to age, sex, race, and other
population of the United States, 1-74 years of age. socioeconomic and demographic factors as well as
These estimates from the National Center for Health related medical history.
1
The principal findings from this eye examination in
the National Health and Nutrition Examination Sur-





An estimated 70.5 per 1,000 persons ages 1–74
years in the United States were found to have
treatable eye conditions so severe or potentially
severe that they either are or should be receiving
medical care.
About half of those in need of medical care for eye
conditions were receiving such treatment.
An estimated 72.7 per 1,000 of the population ages
1–74 years had a type of eye pathology found to be
causing a decrease in visual acuity.
The principal conditions causing decrease in vision
were cataract and/or aphakia, esotropia or exotro-
pia, macular degeneration, glaucoma, and corneal
opacities. Those for which treatment was needed
but not being received were blepharitis, cataract,
glaucoma, esotropia or exotropia, conjunctivitis,






The prevalence of eye pathology causing decrease
in vision and the need for medical treatment of eye
conditions were observed (but not statistically
:signiiicant) to be greater among persons in the
lowest income bracket (under $5,000 per year)
than among the more affluent.
Urban residents were observed to be more likely
than those living in rural areas to have eye
pathology causing decrease in vision and to need
treatment for such conditions.
Black persons were significantly more likely than
white persons to need medical care for eye patholo-
gy and were observed to be more likely also to have
eye pathology causing vision decrease.
Those living in the South were significantly more
likely than persons in other parts of the country to
have some eye pathology causing decrease in
vision, although the need for care was no greater in
the South than elsewhere.
The survey program
The National Health and Nutrition Examination
Survey (NHANES I), through which these data were
obtained, is one of the major programs of the National
Center for Health Statistics that was authorized under
the National Health Survey Act of 1956 by the 84th
Congress.l
In the National Health Examination Survey pro-
grams, health data are collected by direct standard-
ized(usually single-visit) examinations of probability
samples of the population.2-s From these examinations,
tests, and measurements, data are obtained on the
prevalence of medically defined illness-known as well
as previously unknown or undiagnosed conditions—
and on the distributions of a variety of health-related
physical, physiological, and behavioral measurements.
From these, normative data as well as appropriate
cutoff points for abnormalities can be determined. Also
collected are medical histories and demographic and
socioeconomic data on the sample population under
study with which the examination findings can be
interrelated.
The first National Health and Nutrition Examina-
tion Survey was designed to measure the nutritional
status of the U.S. population ages 1–74 years and to
obtain information on other selected aspects of
health-including dental, skin, and eye-of the entire
age group as well as more detded tiormation on
health status and medical care needs of adults ages
25-74 years in the civilian noninstitutionalized popula-
tion. A description of the specific content and plan of
operation, including sample design and the data
collection forms, has been published.G
The U.S. Bureau of the Census participated in
designing the national sample and in the initial
interviewing in the eligible households in the selected
primary sampling units (PSU’S) in various parts of the
country. Members of the mobile exarninin g center staff
did further interviewing and explaining of the exami-
nation portion of the program. The sample persons for
whom appointments could be made were brought into
the specially constructed mobile examination centem
that were moved into a central location in each of the
PSU’S. The team that traveled to the survey locations
throughout the country included profmsional and
paraprofessional medical and dental examiners along
with technicians, interviewers, and management
SM.
The probability sample design used in the survey
provided for oversampling at predetermined rates
among the poor, preschool children, women of child-
bearing ages, and the elderly, so that the nutritional
status of these high-risk groups could be more accu-
rately estimated. It fmher provided for a nationally
representative subset of 35 of the initially planned
PSU’S throughout the United States so that some
preliminary national iindings on the nutritional status
of the population could be published before the total
survey was completed. This also made possible esti-
mates from those parts of the examination which were
included only in this 35-PSU subsample.
During the planning for NHANES I, the National
Eye Institute (NEI) indicated an interest in obtig
more definitive information than was available on the
prevalence and distribution of specific eye diseases and
related conditions throughout the United States as an
aid in setting goals and priorities for emphasis in NEI
programs. Consistent with the overall objectives of the
survey, an evaluation of the treatment needs also was
incorporated into the examination.
Two senior ophthalmologists from NEI, Drs.
James P. Gardey and Arthur J. Garcia, developed the
examination form and standardized protocol for the
ophthahnic examination. They were responsible for
recruiting and training the ophthalmologists in the
examination methodology to minimize interobserver
variations as well as for ver@ing the resultant diag-
noses and for other aspects of quzdity control related to
special equipment used in this examination.
The National Center for Health Statistics and NEI
jointly decided that the ophthalmology examination
would be discontinued after the completion of exami-
nations at 35 locations because of the difficulty of
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securing ophthalmologist examiners. Although the size
of the sample was not as large as originally planned,
these unique national eye examination findings did
provide the basis for the analysis needed to meet many
of the original purposes of this part of the examination.
Howeverj the examined sample is too small to provide
reliable national estimates for conditions of low preva-
lence and the degree of demographic-socioeconomic
detail that would have been desirable for planning
purposes related to medical care needs in this area.
For the 35 locations at which the ophthalmology
examination was given during April 1971 through
October 1972, a national probability sample of 14,147
persons was selected to represent the 192.7 million in
the target population ages 1-74 years. Those under the
age of 1 year were excluded from the sample as were
persons 75 years or over because of the difficulties of
arranging to bring them into the examining units.
Despite intensive efforts, only 10,126 of the sample
persons came in for examination. This represents an
equivalent of 72.8 percent of the sample persons
selected when adjustments are made for the differential
sampling rates for the age-sex-income-defined popula-
tion subgroups. The unadjusted overall response rate
was 71.6 percent.T Of the 10,126 examined, 9,878 were
given the ophthalmology component. This specialty
examination was missed for 244 persons because of
illness of the ophthalmologist examiners or complica-
tions in other parts of the examination.
National estimates in this report are based on
weighted observations; that is, the data obtained for
each examined person are inflated to the size of the
total population of which the sample was representa-
tive using the reciprocal of the sampling ratio for the
original selection and adjustment for nonresponse.
This assumes that the examined person in each of the
age-sex-income classes is a random subsample of the
sample persons in the same class (appendix I). Al-
though there is evidence from the earlier examination
survey and medical history data from the National
Health and Nutrition Examination Survey that these
are not unreasonable approximations, it is clear t!hat
some estimates may be subject to considerable bias
when more than one-fourth of the sample persons in a
particular age-sex-income class were not examined.
The characteristics of examined and nonexamined
persons were reviewed. From this review of what is
known about nonrespondents and the nature of non-
response, the likelihood of sizable bias is believed to be
small.
]Findingsthat are statistically significant as Well as
observed differences (not statistically significant at the
5-percent probability level) that may be of interest are
discussed. Statistically significant diRerences at the 5-
percent probability level are pointed out.
Statistical notes on the sample design, reliability of
the data, and sampling and measurement error are
included in appendix I. The ophthalmology examina-
tion protocol is described in appendix H, which also
includes the recording form used. Data based on the
six-digit National Eye Institute codes, including those
too unreliable for use in the text or detailed tables, lmay
be found in appendix 111 to show more complete
infcmnation on the precise conditions causing vision
decrease or needing car% definitions of the demograph-
ic amd socioeconomic terms used are in appendix V.
The correspondence of the eye conditions identified by
site and type from this examination under this NEI
system with the principal types in the Eighth Revision
International Classljication of Diseases, Adapted for
UM in the United States (lCDA-8)8 as used in this
report are included in appendix IV.
Ophthalmology examination
At each of the 35 selected locations throughout the
country, 10 sample persons were scheduled to come or
be brought into the specifically designed mobile center
for each of the morning, afternoon, and evening
examination sessions. Examinees included two adults
(25-74 years of age) selected to be given the detailed
examination in addition to the more limited examina-
tion for the nutrition sample. The ophthalmology
examination, one of the first procedures scheduled in
each session, was similar for persons in the nutrition
sample and those in the detailed sample except that a
more complete refraction was given the latter group.
The standardized eye examination for all examin-
ees included taking an ocular history regarding known
eye disorders or previous surge~, determination of
monocular distance visual acuity with usual correc-
tion, if any, and with a pinhole test to measure
correctability for those with acuity less than 20/2Q
determination by inspection and standard testing of
the type of motility defects; measurement of prescrip-
tions in present glasses; dilatation and, within 20 to 70
minutes thereafter among those with acuity less than
20/40, retinoscopy for detailed examinees and spheri-
cal trial lens tests for nutrition examinees; applanation
tonometry on examinees ages 20 years and oveq and
examination of the pupils, lids, globes, conjunctival,
sclera, corneas, anterior chambers, irides, and lenses.
The pupils were dilated (except in persons determined
on careful examination to have narrow angle glaucoma
in which the angle was 10° or narrower) for the
spherical refraction and retinoscopy and for the
examination of the vitreous and retina.
The methods used for visual acuity testing, mobili-
ty testing, pinhole testing, and refraction have been
described in the two Series 11 reports analyzing these
tindings from the NHANES I survey.$’~loThe special
procedures used in the various parts of the eye
examination are described in appendix II.
Classification of disease or other
pathologic conditions
The eye conditions diagnosed in this ophthalmic
examination were classified using a six-digit
Ophthalmic Disease Code adapted for use in this
survey by the National Eye Institute. The first two
digits refer to the anatomical site of the disease or
injury except for the digits 61, which refer to refractive
errors. The second two show the nature or type of
disease, injury, or surgical or nonsurgical treatment.
The last two identify the etiology of the disease, agent
of injury, nonsurgical or surgical treatment indicator,
and postoperative state indicator. Data from the entire
six-digit NEI diagnoses codes for all conditions occur-
ring at least 10 times and for all conditions decreasing
vision, in need of but not receiving medical care, as well
as those under medical care are included in appendix
HI. These are included for reference purposes to show
more precisely the specific eye conditions causing
vision decrease or needing care, although many of
these estimates are not sufficiently reliable for inclusion
in the tables and text because of the small numbers of
individuals identified with rare conditions and the
excessively large sampling variabilityy.
Tables 3-5 contain the prevalence of eye condi-
tions identified from the first four digits of the NEI
codes—showing site and type of disease-under the
NEI system (table 3) and after conversion to ICDA-8
(tables 4 and 5). These tables are included to give an
idea of the various types of eye problems in the
population needing care or causing vision decrease
although, because of the small sample for which these
data are available, they contain more than the usual
number of cells with estimates that do not meet the
standard of reliability and precision used for state-
ments and the major tables in this report.
Quality control
Procedural manuals for the ophthalmological ex-
amination were available to the examiner in each
location, as an aid in maintaining standard protocol.
In addition, the senior ophthalmologists from NEI
developed a protocol for supervised testing, to ensure
the accuracy of the ophthalmology examination data
and to aid in maintaining uniformity in the examina-
tion procedures.
Examinations of all sample persons in the first two
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sessions at 24 of the 35 stands were observed and Aclditional diagnoses showing site and type (but not
partially replicated by the senior ophthalmologists etiology, vision decrease, or need for medical care)
from NEI, who then evaluated the methods and were added during medical review at NEI using
findings of the examiners and made recommendations criteria as consistent as possible with those used by the
when needed. The extent of examiner variabilityy, examining ophthalmologists. This was done to ensure
which cannot be separated from the sampling variabili- uniforrnity in interpretaticm of the diagnostic criteria
ty inherent in the survey, is discussed in appendix I. throughout the study.
Total prevalence
More than one-third (381 per thousand) of the
population ages 1-74 years in this country, or an
estimated 73.5 million persons in 1971–72 had, some
abnormality in one or both eyes, either physiologic or
pathologic, excluding those limited to refractive errors,
arcus senilis, conjunctival melanosis, concretions, pin-
guecula, inclusions, follicles, and nonsymptomatic
phorias (table 1). These conditions ranged from minor
ones that do not and may never interfere with normal
functioning to more serious types causing visual loss or
requiring treatment.
These abnormalities do not necessarily reflect
significant abnormalities, but include any changes—
benign, pathologic, or physiologic— from the norm of
ocular morphology, structure, or function. For exam-
ple, an individual was considered to have refractive
changes in the eye whether conditions were minor or
insignificant, such as a myopic cup, conus or crescent
or the more significant pigmentary changes in myopic
macula.
The prevalence rates of eye pathology increased
with successive age groups from 105 per 1,000 pre-
school children ages 1-5 years to 854 per 1,000 adults
ages 65–74 years (figure 1). Females were about as
likely as males to have some type of eye patholog~ the
prevalence rates were 374 and 389 per 1,000 popula-
tion, respectively (table 1). Across age groups 6-54
years, the prevalence of eye pathology among males
was observed to consistently exceed that among
females; among the preschool-age population and
older adults ages 55–74 years, the rates for females
were about the same as for males.
Among the population with eye pathology, the
majority (57 percent) had only one type of condition,
23 percent had two, and the remainder had as many as
12 per person. The total prevalence of eye conditions
was 677 per 1,000 population ages 1–74 years. The
increase with successive age group in the prevalence of
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Figure 1. Prevalence rates for eye conditions and the proportion of the
population with one or more types of eye pathology among persons
ages 1-74 years by age United States, 1971-72
35–74 years than that shown for the proportion of the
population affected in any degree, reflecting the in-
crease in the multiple eye conditions with age.
Types of eye pathology
Parts of the eye most frequently affected by these
physiologic and pathologic conditions were the retina
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(126.0 per 1,000 population ages 1-74 years), the
crystalline lens (116.6 per 1,000), the cornea (111.3 per
1,000), the lids (71.4 per 1,000), and the neuromuscu-
lar system of the eye (56.9 per 1,000).
The prevalence of conditions affecting the retina,
crystalline lens, and cornea increased rapidly with age
(table 2 and figure 2), while the prevalence for those
Meeting the lids and neuromuscular system of the eye
showed no consistent age-related trend until 35 years
of age (figure 3). Amblyopia (poor vision in one eye
that appears to have no organic disease or one that
could be identified by the examiner) is more prevalent
among adults ages 25–74 years than among children
and younger adults. “Refractive” conditions, which
showed no consistent trend with age (table 2), are
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Figure 2. Prevalence rates for eye conditions affecting the retina and
cornea among persons ages 1-74 years by age United States, 1971-72
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Figure 3. Prevalence rates for eye conditions affectinc! the fids and
neuromuscular system of the eyes among persons ag& 1-74 years
by age United States, 1971-72
error such as myopic disc or Fuchs’ spot; these
changes refer exclusively to myopic refraction, because
hyperopia is not associated with structural changes
other than small cornea or globe.
Conditions affecting the cornea were observed to
be more prevalent among males than females (128.0
per 1,000 males compared with 95.6) as were those
affecting the lids (80.3 per 1,000 males compared with
613.0).Females were about as likely as males to have
conditions affecting the crystalline lens (123.0 per
1,000 females compared with 109.8 per 1,000 males).
~4mblyopia occurred significantly more frequently in
females than males (32. 1 per 1,000 females and 17.4
per 1,000 males).
Across successive age groups, the prevalence of eye
pathology affecting the cornea was greater among
males than females with differences in rates large
enough to be statistically significant at ages 1–5 and
:12-44 years. Also across ages to 65 years, amblyopia
was observed to occur more frequently in females than
males. The estimated prevalence of neuromuscular eye
pathology was consistently (but not significantly)
greater among females than males across the age range
of 1–74 years; the sex difference trend with age in the
prevalence of abnormal conditions affecting the lids
and crystalline was less consistent.
The principal types of eye pathology (table 3),
using the NEI classification system, were changes
:tiecting retinal vessels (84.7 per 1,000 population),
opacity or sclerosis of the crystalline lens (56.6 per
1,000 population), corneal opacities (33.5 per 1,000
population), cataract (33.4 per 1,000 population),
{drusen (29.6 per 1,000 population), blepharitis (24.3
:per 1,000 population), amblyopia (significant
difference in refractive error of the two eyes, usually
secondary to strabismus or anisometropia—25.0 per
1,000 population), exotropia (21.3 per 1,000 popula-
tion), and pterygium (16.0 per 1,000 population).
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Corneal opacities and pterygium were more fre-
quently found among males than females and more
frequently among adults ages 45–74 years than youn-
ger adults or children, although the increase in
prevalence across successive age groups was not
consistent.
The prevalence of the other more frequently
occurring types of eye pathology generally increased
across successive age groups, the trend being most
consistent for retinal vascular changes, opacities and
cataract of the lens, and drusen of the choroid. Sex
differences and age trends in the prevalence of these
conditions were not marked enough to be statistically
significant at the 5-percent probability level.
In terms of the more widely used ICDA–8 as
shown in table 4, the most prevalent types of eye
pathology among the U.S. population ages 1–74 years
were cataracts (rate of 93.9 per 1,000 population),
arteriosclerotic changes affecting the retinal vessels
(84.7 per 1,000), strabismus (40.9 per 1,000), comeal
opacities (35.2 per 1,000), blepharitis (26.4 per 1,000),
pterygium (16.3 per 1,000), conjunctivitis (13.3 per
1,000), and congenital abnormalities of the eyes other
than strabismus (9.7 per 1,000). Estimates for these
conditions cannot be derived from the data based on
the NEI classification shown in table 3 because in that
table conditions with very low prevalence (less than
0.5 per 1,000) have been grouped with “all other” for
the part of the eye affected.
Cataracts
The prevalence of cataracts, defined here as any
loss of transparency of the Iensll which mayor may not
be associated with loss of vision, increased with
successive age groups from a rate of 4.5 per 1,000
preschool age children 1-5 years to 576.4 per 1,000
adults 65-74 years (figure 4). The rate of increase was
most rapid from ages 45 years on. Proportionately
more females than males had evidence of a cataract
(figure 5); the rates were 103.3 and 83.8, respectively (a
difference large enough to be statistically significant at
the 5-percent probability level).
Changes tiecting retinal vessels
These conditions also showed a rapid generally
significant increase in prevalence with age from 8.7 per
1,000 among preschool children ages 1–5 years to
364.2 per 1,000 among adults ages 65–74 years (figure
6). The most rapid rates of increase were among adults
from ages 35 years on. Such conditions were observed
to be only slightly more prevalent among females than
males (87.7 compared with 81.6 per 1,000, respective-
ly).
Strabismus
Strabismus (heterophoria or cross-eyes), which
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Figure 4. Prevalence rates for selected noninflammatory conditions of
the eyes-cataracts, corneal opacities and pterygiubmong per-
sons ages 1-74 years by age: United States, 1971-72
was more prevalent among adults ages 55-64 years
and less prevalent among preschool children ages 1-5
years than at other ages. The rates also were observed
to be somewhat higher among teenagers ages 12–17
years, adults ages 45-54 years and those ages 65–74
years than younger children or younger adults, al-
though there was no consistent age-related trend.
Females were more likely than males to have such a
condition (rates of 49.9 and 31.2 per 1,000, respective-
ly).
Opacities
The prevalence of opacities resulting from healed
corneal injuries, infections, or other causes ranged
from 2.7 per 1,000 among preschool children ages 1-5
years to 70.3 per 1,000 adults ages 65-74 years. The
rates were observed to be higher among adults ages
45-74 years and those ages 18-24 years than younger
adults or children but showed no consistent increase
with age. Males were significantly more likely to have
such conditions than females; the rates were 49.6 and
21.9 per 1,000, respectively. This would be expected,
because injuries are a major cause, and men would
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Figure 5. Prevalence rates for the principal types of eye conditions among persons 1-74 years of age: United States, 1971-72
occupations or strenuous sports where such accidents
frequently occur.
Blepharitis
Inflammation of the margin of the eyelids caused
by bacteria or seborrheal] had observed prevalence
rates at a minimum of 14.6 per 1,000 for ages 1–5 years
and a maximum of 41.9 per 1,000 among the oldest
adults in the study, 65–74 years, with no consistent
age-related trend. The prevalence was significantly
higher among males (32.2 per 1,000) than females
(20.9 per 1,000).
Neoplasms
The prevalence rates of malignant and benign or
unspecified neoplasms affecting the eye and surround-
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ing tissue generally were observed to increase with
successive age groups from 1.9 per 1,000 preschool
children ages 1-5 years to 63.5 per 1,000 adults ages
65–74 years. Males were observed to be slightly more
likely than females to be afkted with rates of 27.9,
compared with 22.3 per 1,000, respectively.
Pterygium
This condition, in which a triangular fold of bulbar
conjunctival advances over the cornea, occurs most
frequently among persons exposed to chronic ccmjunc-
tival irritation from wind and sunlight. 11The condition
was found only among adults ages 18 years and over.
The prevalence rates generally were observed to
increase with successive age groups from 3.0 per 1,000
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Figure 6. Prevalence rates for selected types of eye conditions amen
persons 1-74 years of age, by age United States, 1971-72
1,000 among adults 55-74 years of age. More than
three times as many males as females were affected, the
rates being 25.4 and 7.6 per 1,000, respectively.
Conjunctivitis
This inflammation of the lining of the posterior
surface of the eyelids and anterior surface of the globe
caused by infection, allergy, or other irritant,l 1showed
no consistent age-related trend. The prevalence was at
a maximum for ages 12-17 years (20.0 per 1,000) and a
minimum for ages 55–64 years (7.2 per 1,000). Males
were significantly more likely to be affected than
females (rates of 16.4 and 10.3 per 1,000, respectively).
Congenital eye conditions
Excluding strabismus, congenital eye conditions
showed no consistent trend with age. The prevalence
rates ranged from a minimum of 6.8 per 1,000 persons
ages 35+4 years to a maximum of 13.1 among youths
12-17 years. Males were observed to be slightly more
likely than females to have such eye conditions; the
respective rates were 11.2 and 7.9 per 1,000.
Causes of blindness
Among these various types of eye pathology, the
principal causes of blindness are cataract, glaucoma,
diabetic retinopathy, and macular degeneration.
The most prevalent of such conditions were
cataracts, which were found among an estimated 18
million persons, or 93.9 per 1,000 population, ages
1–74 years (table 4). Nearly three-fourths of those
persons showed substantial evidence of cataract on
examination ranging from immature to mature condi-
tions. aphakia, and lens opacities. Macular degen-
eration was identified in an estimated 2.5 million persons or
13.1per 1,000population (table 3).
Definite or probable glaucoma conditions were
found among an estimated 1.3 million persons, or 6.4
per 1,000 of the population. An additional 2.4 per
1,000 persons had conditions considered suspect of
glaucoma—with evidence of open or wide angle,
narrow angle or angle closure, or substantially in-
creased intraocular pressure. Approximately one-third
of those with definite or probable glaucoma and one-
fifth of those with suspect conditions showed physical
evidence of glaucomatous cupping in the disc. Because
visual fields were not tested in NHANES, these rates
for glaucoma will probably be underestimates of the
total prevalence.
Diabetic refinopathy was identified among an
estimated 1.9 per 1,000 population. About one-fourth
of these were observed to show definite evidence of
diabetic involvement of the macula and an additional
one-fourth, microaneurisms or neovascularization
and/or hard or waxy exudates on the retina. These
latter proportions, because of the smallness of the
available national sample, do not meet the standards
for reliability and precision used in this report.
Vision decrease
An estimated 72.7 persons per 1,000 population
ages 1-74 years had one or more types of eye
abnormalities causing a decrease in visual acuity, as
observed by the examining ophthalmologist in the
1971–72 NHANES. The prevalence of conditions
causing visual impairment increased from 11.0 per
1,000 children ages 1–5 years to 363.7 per 1,000 adults
ages 65–74 years; the rate of increase was most rapid
among older adults ages 55–74 years (figure 7). Males
were somewhat less likely than females to have such
conditions; the rates were 65.7 and 79.2 per 1,000 ages
1–74 years, respectively. The trend with age was
similar for both sexes, and the rates for males generally
remained lower than those for females across ages
(table 6, figure 8).
The principal conditions causing vision decrease
were cataract and/or aphakia (affecting an estimated
29.3 per 1,000 persons ages 1–74 years), esotropia or
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Figure 7. Prevalence rates for eye pathology (one or more conditions),
eye pathology causing vision decrease, and need for medical
treatment of eye condition (s) among persons 1-74 years of age, by
age: United States, 1971-72
per 1,000), glaucoma (3.0 per 1,000), and corneal
opacities (1.7 per 1,000).
Among those with eye pathology, about one out of
five had conditions causing vision decreasq the pro-
portion varied between 10 and 13 percent at ages 1-44
years, then increased rapidly with age to 43 percent at
65–74 years (figure 8). This age-related trend was
generally similar for males and females. The conditions
most likely to cause vision decrease were detached
retina (62 percent of those with such pathology),
glaucoma (47 percent), other conditions of the retina
including macular degeneration (46 percent), cataracts
(31 percent), symptomatic conditions affecting the
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Figure 8. Prevalence rates for eye pathology causing vision decrease
among persons ages 1-74 years, by age and sex United States,
1971-72
uveal tract (20 percent), strabismus (16 percent,), and
the inflammatory condition of keratosis (14 percent)
(table 5).
Need for treatment
The proportion of the population needing treat-
ment for one or more types of eye pathology was
estimated at 34.2 per 1,000 population ages 1-74.years,
based on the evaluation of the examining ophthalmolo-
gists in the 1971-72 NHANES. The prevalence of
need for treatment was nearly 25 per 1,000 population
across ages 1-44 years (varying between 16.5 :at ages
6+11 years to 30.7 at 25-34 years) then increased
consistently with age to 98.2 per 1,000 population at
65-74 years (table 6, figure 9).
Males ages 1–74 years were about as likely as
females to need treatment for an eye condition; the
rates were 33.8 and 34.6 per 1,000 population, respec-
tively. The trend with age was similar for males and
females except among the oldest age group (65-74
years), where the rate was significantly higher among
men (120.9 per 1,000) than women (81.2 per 1,000).
The principal conditions needing treatment were
o~
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Figure 10. Prevalence rates (age-adjusted) for eye pathology, eye
conditions causing decrease in vision, eye conditions needing but
not receivina medical treatment, and eve conditions for which care
blepharitis (affecting an estimated 5.4 per 1,000 per-
sons 1–74 years), cataract (4.5 per 1,000), glaucoma
(3.6 per 1,000), esotropia or exotropia (2.8 per 1,000),
conjunctivitis (2.6 per 1,000), retinal vascular changes
(1.6 per 1,000), pterygium (1.6 per 1,000), and benign
or malignant neoplasms (1.5 per 1,000).
Nearly 9 percent of those with some type of eye
pathology needed treatment and were not receiving it.
The proportion was highest among preschool children
ages 1–5 years (20 percent) but otherwise showed no
consistent age-related trend, varying between a low of
6 percent at ages 35-44 years and 11 percent at 12–17
and 65-74 (figure 10). This pattern was generally
similar among males and females except at 65–74 years
where among those with eye pathology, the proportion
of men needing treatment was approximately twice
that among women (18.9 percent and 9.5 percent,
respectively).
Among those with eye pathology, the conditions
most likely to need treatment as determined in the
examination, were glaucoma (56 percent), hordeolum
or styes (25 percent), blepharitis (20 percent), conjunc-
is being rec&ed among white and black persons 1-74 years of age:
United States, 1971-72
tivitis (20 percent), inflammatory conditions of the
uveal tract (11 percent), and pterygium (10 percent).
Under care
In addition to the 34.2 per 1,000 population ages
1–74 years who were in need of but not receiving
treatment for eye pathology, 36.3 per 1,000 were
receiving care at the time of the survey for one or more
eye conditions (table 6). Therefore, about half (52
percent) of the total population needing treatment for
eye pathology was receiving it.
Among males, the additional 31.0 per 1,000 in
need treatment for an eye condition and receiving it
were slightly less than half of the total needing
treatment (64.8 per 1,000); among females, the esti-
mated 41.1 per 1,000 under care were slightly more
than half of the total in need of such treatment (75.7
per 1,000). The principal eye conditions for which
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medical treatment was being given were esotropia or
exotropia (6.3 per 1,000), cataracts (3.9 per 1,000),
glaucoma (2.0 per 1,000), retinal vessel changes (1.8
per 1,000), conjunctivitis (1.4 per 1,000), and pterygi-
um (1.2 per 1,000).
Of the total population ages 1-74 years in need of
and/or receiving medical treatment for these principal
types of eye pathology, those most likely to be
receiving medical care were persons with detached
retina (84 percent), esotropia or exotropia (69 percent),
retinal vessel changes (53 percent), substantial refrac-
tive errors (50 percent), corneal opacities (47 percent),
cataracts (46 percent), and pterygium (43 percent). In
contrast, only about one-third or fewer persons with
glaucoma (36 percent), conjunctivitis (35 percent),
benign or malignant neoplasms (29 percent), and
blepharitis(11 percent) were under care.
Intraocular pressure
National estimates for the distribution of intraocu-
lar pressure levels among adults from tonometry
measurements obtained in NHANES are shown in
table 7. Although elevated intraocular pressure is one
characteristic of glaucoma, the ability of the healthy
eye to tolerate indefinitely elevated pressure of 20 mm
Hg as measured by Schiotz tonometry (the equivalent
of approximately 19 mm Hg on the applanation
readings obtained in this study) without damage to the
optic nerve is recognized. 11Persons with previously
diagnosed glaucoma who are under treatment would
be expected to have intraocular pressures maintained
at normal levels through medication. The relationship
of the diagnoses of glaucoma and the intraocular
pressure levels has not been included in this report.
Among U.S. adults 20-74 years of age, the mean
intraocular pressure (determined from the average of
the three applanation tonometry measurements) was
14.8 mm Hg. Mean levels were observed to increase
negligibly with successive age groups from 14.2 mm
Hg at ages 20-24 years to 15.8 mm Hg at 65–74 years
and were generally similar among men and women
(14.7 and 14.8 mm Hg, respectively).
Nearly one-half (46 percent) of the population ages
20-74 years had intraocular pressures of 15 mm Hg or
greateq the proportion increased with successive age
groups from 35 percent among the youngest adults
tested, ages 20-24 years, to 59 percent among those
65–74 years. At ages 20-24 years, the proportion with
this degree of pressure elevation was observed to be
slightly higher among men (38 percent) than women
(32 percent); at 65-74 years of age, the reverse was
found (55 percent of men compared with 62 percent of
women had this degree of elevation).
Elevated intraocular pressure of 20 mm Hg or
more was found among 5 percent of adults 20-74 years
of age. This proportion increased substantially with
successive age groups from 2 percent among young
aclults ages 20-24 years to 10 percent among those
ages 65-74 years. The increase in this degree of
pressure elevation with age groups was observed to be
silmilar for men and women.
The total eye problem
In summary, an estimated 381.1 per 1,000 of the
U.S. population ages 1–74 years in 1971–72 had one or
more types of eye pathology as identified in this
NHANES examination. Nearly one-fifth (18.5 per-
cent) of these, or an estimated 13.6 million persons,
with eye pathology were either receiving or in need of
treatment for the condition (table A). Nearly om[e-half
of this grou@8. 5 percent (an estimated 6.6 million
persons)—were not receiving but needed such treat-
ment.
Nearly one-fifth (19. 1 percent) of those with eye
pathology, or an estimated 14.0 million persons, had
an eye condition causing decrease in visual acuity.
Defective acuity of no better than 20/50 in one or
both eyes with usual correction (with corrective lenses
if worn, otherwise without), as determined in the
NHANES, was found among an estimated 61.5 per
1,000 population ages 4-74 years. (This corresponds to
the rate of 59.2 per 1,000 ages 1-74 years shown in
ta~ble B, assuming no defective acuity among those
whose vision was not tested—those 1-4 years of age).
Nearly three-fourths (74.3 percent) of persons, 1–74
years with usual visual acuity 20/50 or worse (or about
8.5 million) also had some eye pathology. Nearlly half
of them (47.8 percent), or 5.4 million persons 1-74
years, had some eye pathology causing decrease in,, .
Vllslon.
More than three-iifths (61.1 percent) or an estimat-
ed 8.6 million persons 1-74 years of age with eye
pathology causing vision decrease still had acuity
better than 20/50 with their usual correction.
F{ace
Vision decrease
The prevalence of eye pathology causing decrease
in visual acuity was slightly, but not signMcantly
greater among the black than the white population
ages 1–74 years; the estimated rates were 78.7 and 72.1
per 1,000 population, respectively. However, when the
rates were standardized to remove the effect of
differences in the age distributions of the two popula-
tions, the rate for eye pathology causing vision
decrease was significantly greater among black persons
(95.0 per 1,000) than among white persons (70.6 per
1,000) (table 8). These racial differences were observed
among males and females.
Across age, these rates were observed to be
somewhat higher for black than white males from ages
12–74 years. Among females, the pattern of’ racial
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Table A. Prevalence rates and prevalence of eye pathology, eye pathology causing vision decrease, and defective usual visual acuity
(20/50 or worse) among persons 1-74 years of age, by sex United States, 1971-72
Type of eye condition Total Males Females
Eye pathology, one or more &pes..........................................................................................
Eye pathologyneeding or receiving treatment ......................................................................
Treatment needed (not under care) ....................................................................................
Under care ...............................................................................................................................
Eye pathology causing vision decrease ..................................................................................
Usual visual acuity 20/50 or worse ........................................................................................
No eye pathology, usual acuity 20/50 or worse .............................................................
Eye pathology, usual acuity 20/50 or worse ....................................................................
Eye pathology causing vision decrease, usual acuity 20/50 or worse .......................
Eye pathology causing vision decrease but usual visual acuity still better than
20/50 ..........................................................................................................................................-
Eye pathology, one or more Wpes ..........................................................................................
Eye pathology needing or receiving treatment ......................................................................
Treatment needed (not under care) ....................................................................................
Under care ...............................................................................................................................
Eye pathology causing vision decrease ..................................................................................
Usual visual acuity 20/50 or worse ........................................................................................
No eye pathology, usual acuity 20/50 or worse .............................................................
Eye patholbgy, usual acui~ 20/50 or worse ....................................................................
Eye pathology causing vision decrease, usual acuity 20/50 or worse .......................
Eye pathology causing vision decrease but usual visual acuity still better than
20/50 .......................... ................................................................................................................
differences in these eye conditions causing vision
decrease was less consistent—the rates among white
females was the higher in age groups 1-11, 18-24, and
45–64 years.
Black males were observed to be more likely to
have eye pathology causing vision decrease than black
females (age-adjusted rates of 102.8 and 88.4 per 1,000,
respectively); the reverse was observed in the white
population, among whom the age-adjusted prevalence
rate was 62.5 per 1,000 white males, compared with
78.2 for white females.
Among the white population, the prevalence of eye
pathology causing vision decrease was substantially
lower for younger females than males from 1-34 years
of age; among black persons the pattern of sex
differences with age in such pathology was less









greatei a-mong black than white persons (age-adjusted
~ates of 59.4 &d 31.6 per 1,000, ~espective~) (table 9).
Among males and females, the relative extent of need
for such care was significantly greater among black
than white persons ages 1-74 (age-adjusted rates of
53.3 compared with 32.1 per 1,000 males and 64.9
compared with 31.2 per 1,000 females).
White males were observed to be about as likely as
white females and black females as more likely than
black males to have eye conditions needing medical






















care. Among adults 18-74 years, the need for eye
treatment was significantly greater for black men and
women than it was for their white counterparts (71.3
and 78.7 per 1,000 black men and women, compared
with 36.6 and 36.3 per 1,000 white men and women).
Among the population with eye pathology, the
proportion needing treatment was observed to be
greater for black than white persons, for males and
females (8 percent among white males and females, 11
percent for black males and 16 percent for black
females).
Under care
The proportion of the population with eye patholo-
gy being treated was observed to be greater among the
white than the black population ages 1-74 years (age-
adjusted rates of 38.0 per 1,000 white persons and 25.0
per 1,000 black persons)(table 10).
When considered in relation to all of those needing
treatment for eye pathology, whether or not they are
now receiving it, over half the white population ages
1–74 years in need of such care were receiving it (55
percent for both sexes, 50 percent for males and 58
percent for females), compared with only slightly more
than one-fourth among the black population (28
percent for both sexes, 26 percent for males and 29
percent for females).
Among adults 18–74 years of age, nearly 79
percent of the group of white women needing eye
treatment were receiving it, compared with 51 percent
of white men, 32 percent of black women, and 28
percent of black men.
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Geographic region Northeast and Midwest, males were about as likely as
females to be under care (53 and 54 percent, and 50
Vision decrease
Eye pathology causing decrease in vision was most
prevalent in the South and least prevalent in the West
among the total population ages 1–74 years, and
among adults 18–74 years, males and females; the
differences were large enough to be statistically sig-
nificant. Age-adjusted rates ranged from 89.6 per 1,000
in the South to 53.9 per 1,000 in the West for the
population ages 1–74 years; those in the Northeast and
Midwest were similar (72. 1 and 73.9 per 1,000,
respectively)(table 8).
Treatment needs
The age-adjusted proportion of the population l–
74 years of age in need of treatment for one or more
eye conditions ranged from 40.4 per 1,000 in the West
to 29.9 per 1,000 in the Northeast, differences too
small to reflect no more than sampling variability.
Among adults, the range was from 54.6 per 1,000 in
the West to 31.6 per 1,000 in the Midwest (table 9).
Among males, the regional distribution of need for
treatment was generally similar to that shown for the
total population ages 1–74 years. The age-adjusted
rates ranged from 47.2 per 1,000 in the West to 25.0
per 1,000 in the Northeast; the differences between
these extremes were large enough to be statistically
significant.
Among females, the proportion of the population
in need of treatment for an eye condition showed
essentially no regional variation. The age-adjusted
rates for the ages 1–74 years ranged from 34.7 per
1,000 in the West to 33.5 per 1,000 in the Northeast;
among women 18–74 years, the range was from 44.7
per 1,000 in the West to 32.2 in the Midwest.
Under care
The age-adjusted proportion of the population
under care for an eye condition ranged from 41.2 per
1,000 in the South to 33.8 in the West, differences
small enough to reflect no more than sampling
variabilityy (table 10). Among males, these rates were
observed to be slightly higher in the Midwest and
lower in the West and Northeast than the South; the
proportion of the female population receiving treat-
ment for an eye condition was highest in the South and
lowest in the Midwest.
For the total population with eye pathology who
needed or were receiving treatment for it, the propor-
tion under care ranged from 56 percent in the South to
46 percent in the West. Females in the West and, to a
more limited extent, those in the South, were more
likely than males to be receiving such care (53 percent
compared with 38 percent in the West, 59 percent
compared with 52 percent in the South); in the
and 59 percent, respectively).
Population density
Vision decrease
Eye pathology causing decrease in vision was
observed to be more prevalent among urban than rural
residents. The respective rates were 75.4 and 67.6 per
1,000 population ages 1–74 years (table 8). Urban rates
appeared higher for males and females ages 1–74 years
and adults 18–74 years.
Such eye pathology was most prevalent among
persons living in the smaller nonurbanized communi-
ties of 25,000 or more and the least prevalent among
persons in the largest urban communities of 3 million
or more. The dMerence between these respective age-
adjusted rates of 132.4 and 53.4 per 1,000 was large
enough to be statistically significant. Only in the
largest metropolitan communities were the rates of eye
pathology causing vision decrease observed to be less
than for those in rural areas.
Treatment needs
The extent of need for treatment of an eye
condition was observed to be greater among the urban
than the rural population. The respective rates were
39.7 and 23.8 per 1,000 population ages 1-74. years
(table 9). The greater need for such care was observed
to exist among males and females in urban communi-
ties.
In rural areas, the need for eye treatment was
clbserved to be greater among males than femaley in
umban communities, the need for such care was
generally somewhat greater among females than
males.
IJnder care
The proportion of the population with eye condi-
tions being treated was observed to be greater in urban
than rural areas among males and females (table 10).
In both population density areas, females were ob-
served to be more likely to be receiving treatment than
males.
Of all those in need of treatment for an eye
condition, regardless of whether care was being re-
ceived, about half of those in need of care in rural and
urban areas were observed to be receiving it.
Ilncome
Vision decrease
There was an inverse relationship between eye
pathology causing vision decrease and annual family
















Vision decrease from Treatment needed- Under care for
eye pathology not received for eye eye pathology
pathology
Fkwre 11. Prevalence rates (age-adjusted) for eye pathology, eye conditions causing decrease in vision, eye conditions needing but not receiving
;edical treatment, and eye conditions for which care is being received among persons 1-74 years of age, by annual family income United
States, 1971-72
for such pathology were observed to decrease consist-
ently with increasing income from 84.8 per 1,000
population among those in families with annual
income under $5,000 to 58.0 in those with income
$10,000 or more. This trend for ages 1-74 years as well
as for adults was consistent among males and females.
Treatment needs
The need for treatment of eye pathology was also
observed to decrease consistently with increase in size
of family income. The age-adjusted rates ranged from
41.3 per 1,000 population ages 1–74 years among those
in families with income less than $5,000 to 27.4 per
1,000 in the $lO,OOO-and-overbracket (table 9).
Among adults ages 18–74 years in the population
with eye pathology, the proportion needing medical
treatment was observed to decrease from 50.5 per
1,000 among those in the lowest income bracket
(under $5,000) to 30.3 per 1,000 among those with
annual income of$10,000 or more.
Under care
The proportion receiving treatment for eye pathol-
ogy was observed to show a direct association with
income. The age-adjusted prevalence rates for those
under care ranged from 26.1 per 1,000 population ages
1–74 years with income under $5,000 to 40.6 per 1,000
among those in the $10,000 and over bracket (table
lo).
The age-adjusted proportion under care for eye
pathology among those determined to be in need of or
receiving such care was observed to increase from 39
percent among the population 1–74 years of age in the
lowest income level group to 60 percent among those




among adults 18–74 years
decrease in visual acuity
was observed to show a
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consistent decrease in prevalence
of education. The age-adjusted
151.0 per 1,000 population with
with increasing level
rates declined- from
less than 5 years of
formal schooling to 44.5 per 1,000 population with 13
years or more, a trend consistent among men and
women (table 11).
Treatment needs
The extent of need for treatment of eye pathology
also was observed to be inversely related to the
education level of adults. The age-adjusted prevalence
rates of need for medical care of eye conditions
decreased from 71.4 per 1,000 adults 18–74 years with
less than 5 years of schooling to a minimum of 17.8 per
1,000 among those with 13 years or more education.
In relation to the extent of eye pathology for which
treatment was needed, the age-adjusted proportion was
observed to decrease from 15 percent among adults
with the least education (less than 5 years) to 5 percent
among those with some college education (13 years or
more).
Under care
The proportion of the adult population receiving
care for eye pathology was observed to be somewhat
greater among those with less than 5 years of formal
schooling than among those with more education. The
respective age-adjusted rates were 46.1 per 1,000
population compared with 30.3 and 33.7.
Among all adults receiving or needing treatment
for eye pathology, the proportion being treated was
observed to increase consistently with education from
39 percent among those with less than 5 years of
completed education to 65 percent with 13 years or
more of education.
Comparison with previous studies
National prevalence estimates for eye pathology
based on findings from the three previous National
Health Examination Surveys of 1960-62 among adults
18-79 years of age, of 1963-65 among children 6-11
years of age, and 1966-70 among youths 12–17 years
of age have been published. ‘2-14
The initial National Health Examination Survey
among adults in 1960-62 included a funduscopic
examination performed by the survey physician with
an ophthalmoscope during the physical examination.
The prevalence of eye pathology as determined for
U.S. adults 18-74 years of age in 1960-62, when
standardized with the 1971–72 U.S. population distrib-
ution, was approximately 35 percent, compared with
the prevalence rate of 48 percent among this age range
in the 1971-72 national study (NHANES). The higher
rates in the more recent study were expected because
t:he eye examination was more comprehensive.
In the 1963–65 National Health Examination
Survey among children 6-11 years of age, the examina-
tion by the survey pediatrician was limited principally
to identification of tropias, phorias, and infectious
conditions affecting the lids or conjunctival. The
r,ssultant prevalence rate for eye pathology from the
1963–65 national study among children ages 6-11
years was 9 per 100, compared with the rate of21 per
100 from the 1971-72 NHANES. In the 1966-70
National Health Examination Survey among youths
12–17 years of age, the examination by the survey
pediatrician was more comprehensive than that given
the children in 1963–65, including an inspection of the
sclerae, pupils, and irides not done in the preceding
survey. However, the prevalence of eye pathology
among U.S. youths in 1966-70” was only 8 per 100,
compared with 24 per 100 in the 1971-72 NHANES.
Again, the higher rates from the more recent national
survey would be expected because the eye examination
was more comprehensive than those in 1963-70 among
children and youths.
The prevalence of selected types of eye pathology
was determined in 1973–75 among the still-living
members of the Frarningham (Ma.) study population,
who had been under investigation for coronary disease
riisk factors since 1948 and who were in 1973-7’5 ages
52–85 years.lsJG The eye examination given by oph-
thalmologists included diagnostic identification of
cataracts, diabetic retinopathy, macular degeneration,
and glaucoma. Among the Framingham group, the
prevalence rates found for senile cataract were 9.6
percent, for diabetic retinopathy 1.6 percent, for senile
macular degeneration 4.0 percent, and for open-angle
glaucoma 1.4 percent. For the comparable age group
(65-74 years) the prevalence of senile cataracts among
the Framingham study population were observed to be
only about one-third the size of the national estimates
from NHANES, the rates for diabetic retinopathy and
senile macular degeneration three times as large, and
the rate for open-angle glaucoma twice as large. These
differences may reflect the more thorough eye exami-
nation given the Framingham group and the somewhat
greater diagnostic precision used there. However,
except for the cataract group, the diiTerences did not
exceed the confidence limits for the national estimates
and hence could be due to sampling variability alone.
Information from the National Health Interview
Survey in 1974 on limitation of activity due to visual
impairments among the civilian noninstitutio]~alized
population has been published. 17These data collected
by household interview, although not really compara-
ble with NHANES data for those with vision decrease
from eye pathology, show a similar pattern of associa-
tion with income but not with region or sex.
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Table 1. Prevalence rates and prevalence of eye conditions, number of eye conditions per person, and persons with one or more types of eye conditions among the population
1-74 years by age and sex with standard errors: United States, 1971-72
Number of
Age at examination
eye conditions and sex All ages, 1-5 8-11 12-17 18-24 25-34 35-44 45-54 55-84 85-74
1-74 years years years years years years years years years years
Both sexes
Persons with one or more eye conditions ......................................................................
All eye condtions .................................................................................................................




3 or more ..........................................................................................................................
Males
Males with one or more eye conditions .........................................................................
AH eye conditions .................................................................................................................




3 or more ..........................................................................................................................
Females
Females with one or more eye condtions .....................................................................
All eye conditions .................................................................................................................




3 or more ..........................................................................................................................








Rate per 1,000 population
243 292 320 386














































































763 710 688 631
178 213 218 232
41 59 71 102













261 309 360 398
334 406 481 630
744 695 648 628
203 227 254 222
42 60 79 99



















225 276 283 376







781 723 724 633
153 200 186 242
41 58 63 104
25 19 27 21
Population estimate in thousands
6,031 6,318 8,237 9,341
3,271 3,259 4,338 4,698
2,760 3,059 3,899 4,643
Standard errors of rates
11.2 13.5 23.3 28.1
15.0 17.8 35.0 37.4
































N Table 2. Prevalence rates of eye conditions by part of the eye affected among the population ages 1-74 years according to age and sex with standard errors United States, 1971-72
Age 2 at examination
Site of eye condition
Sex
All ages,
and NEI1 code All ages, 1-5 6-11 12-17 18-24 25-34 35-44 45-54 55-64 65-74
1–74 years years years years
Male Female both sexes







































































Rate per 1,000 population
16 23 30 32
11 ‘4 ●2 6
‘2 *1 *3 6
37 55 50 64
—
28 -26 34 32
*o ●o 1’
36 68 88 114
*o *5 ●2 ●3
‘4 13 7 10
‘4 ●4 11 6
41 30 29 28
7 10 19 50
27 52 47 62
*1 *5 ●3 13
43 47 57 100
8 12 10 13
59 36 46 34












































































lNEl is the National Eye Institute, National Institutes of Health, U.S. Departmentof Health and Human %’ViCeS.
2A~e.S~eCifiC detai[ sho~n only to indicate trends with age, although most of the estimates do not meet NCHS standard for reliability and Precision.
Table 3. Prevalence rate for the more prevalent types of eye conditions by type and part of the eye affected (NEI classification) among the population ages 1-74 years according to
age and sex with standard errors United States, 1971–72
Site and type of eye condition
Age t at examination Sex
and NEI1 code All ages, 1-5 6-11 12-17 18-24 25-34
All ages,
35-44 45-54 55-64 65-74
1-74 years years years years years years
Male Female both sexes










































Macular degeneration ................................. 7670,7672
Pigment changes ......................................... 7694,7695
Neuromuscular system
Esotropia ....................................................... 7862
Exotropia, acquired ...................................... 7864
Hypeflropia .................................................... 7866












































































































































































































































































INEI is the National Eye Institute, National Institutes of Health, U.S. Department of Health and Human Services.
2Age.specific detail shown on[y to indicate trenda with age, although most of the estimates do not meet NCHS standard for reliability and Precision.
Sother than congenital or traumatic.
M
s Table 4. Prevalence rates for principal types of eye conditions (lCDA—8th revision classifications) among the population ages 1-74 years with standard errors
United States, 1971 J72
Age at examination Sex
Eye condition and ICDA code All ages, 1-5 6-11 12-17 18–24
All ages,
25-34 35-44 45-54 55-64 65-74
1-74 years
Male Female
years years years years
both sexes















































































































































































































































































































































































Table 5. Prevalence rates for principal types of eye conditions (lCDA-8th revision classifications)-all eye conditions, conditions causing decrease in
vision, conditions needing but not receiving medical care andcondtions under medical care among the population ages l-74 years with standard
errors United States, 1971-72
Eye condition and ICDA code All eye Decreasing vision Needing care Receiving care All eye
conditions conditions
Neoplasms . . . . . . . . . . . . . . . . . . . 190,224,227,238
Metabolic conditions . . . . . . . . . . . . . . . . . . 270,272
Blood condition (anemia) . . . . . . . . . . . . . . . . . . . 285
Diseases of nerves . . . . . . . . . . . . . . . . . . . . . 350,358
Inflammatory diseases . . . . . . . . . . . . . . . . . 360-367
Conjunctivitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . 360
Blepharitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 361
Hordeolum . . . . . . . . . . . . . . . . . . . . . . . . . . ...362
Keratitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...363
Other, uveal tract . . . . . . . . . . . . . . . . . . . . . ...366
Other, retina . . . . . . . . . . . . . . . . . . . . . . . . . ...367
Other, lacrimal system . . . . . . . . . . . . . . . . . . . 368
Other, other part of eye . . . . . . . . . . . . . . . . . . 369
Other eye conditions . . . . . . . . . . . . . . . . . . 370-379
Refractive errors . . . . . . . . . . . . . . . . . . . . . ...370
Corneal opacities . . . . . . . . . . . . . . . . . . . . . ...371
Pterygium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 372
Strabismus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 373
Cataract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...374
Glaucoma . . . . . . . . . . . . . . . . . . . . . . . . . . . ...375
Detached retina . . . . . . . . . . . . . . . . . . . . . . ...376
Other, in retina . . . . . . . . . . . . . . . . . . . . . . . ...377
Other, in other parts of
eye . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 378
Other neuromuscular
conditions and blindness . . . . . . . . . . . . . . . 379
Diseases of circulatory system
(arteriosclerotic changes) . . . . . . . . . . . . . . ...440
Diseases of skin (eyelids) . . . . . . . . . . . . . . 692,701
Congenital eye conditions . . . . . . . . . . . . . . . . . . 744
Symptoms —exophthaloma,
nystagmus, visual field
de fects . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...781
Accidents, etc. . . . . . . . . . . . . . . . 802, 870, 921, 930
Rate per 1,000 population




56 *2 9 *3
13 *3 ●1
26 *o ●5 *1
●1 ●o *o
*2 *o *o *o




454 82 25 22
5 *o ●o ●o
35 ●2 ●1 *1
16 ●1 “2 ‘1
41 ‘7 ●3 *6
94 29 ●4 ●4
6 ‘3 4 *2
*1 ●1 ●o ●1
78 36 ‘6 ●4
171 *3 ‘4 ●2


























85 ●o ‘2 *2 4.4
6 ‘o 1.1
10 *1 o 0 1.4
7 ●2 *o *1 1.1
5 ●o *o ●o 1.1
NOTE Data included to show relative magnitude of the problem, although the estimates for most do not meet NCHS standards for reliability and precision.
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Table 6. Prevalence rates for eye conditions causing decrease in vision, needing (but not recieving) medical treatment and under medical
care among the population ages 1–74 years by age and sex with standard errors United States, 1971-72
Eye conditions
Age and sex Causing vision Needing Under Causing vision Needing Under
decrease medical care medical care decrease medical care medicai care
Rate per 1,000 population Standard errors
































































Males, 1–74 years .................................. 66 34 31
Females, 1-74 years .............................
. . . . . .,, .
79 35 41 . . . . . . .,, .
1Does not include conditions receiving medical care.
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Table 7. Mean intraocular pressure, standard error of the mean and percent distribution of adults ages 20-74 years in the population by age, sex, and race United States, 1971-72
All races White Black
Tonometry group and sex 20-74 20-24 25-44 45-64 65-74 20-74 .20-24 2544 45-64 65-74 20-74 20-24 25-44 45-64 65-74
years years years years yeare years years years years years years years years years years
Both sexes
All groups ..................................
Less than 10.0 mm Hg ..........
10.0-14.9 mm Hg.....................
15.0-19.9 mm Ha,....................
20.0 mm Hg or more ..............




Population in thousands ..........
Males
All groups ..................................
Less than 10.0 mm Hg ..........
10.0-14.9 mm Hg .....................
15.0-19.9 mm Hg .....................
20.0 mm Hg or more ..............




Population in thousands ..........
Females
All groups ..................................
Less than 10.0 mm Hg ..........
10.0-14.9 mm Ha.....................
15.0-19.9 mm Ha.....................
20.0 mm Hg. and over ...........



































































































































































































































































































































Table 8. Prevalence rates of eye pathology (actual and standardized) causing vision decrease among the population 1-74 years by race,
—
aeoaraDhic reaion, DomJlation size, and income, with selected standard errors United States, 1971-72
Eye pathology causing vision decrease
Characteristic Actua/ rates
—
Standardized rates All ages,
Both sexes Males Females Both sexes Males Females both sexes
Race Rate per 1,000 population Standard error
All racesl ...................................................................... 73 66 79 4.7 —
White
. . . . . .
................ ........................................................ 72 64 80 71 62 “78 4.7
Black .......................................................................... 78 85 74 95 103 88 12.0
Geographic region
Notiheast ....................................................................... 75 58 91 72 57 85 10.0
Midwest ............................... . ...... . ...... . .... .............. 71 65 76 74 66 81 14.3
South ............................................................................. 92 94 91 90 92 87 8.3
West ............................................................................... 52 45 59 54 46 61 7.5
Urban-rural
All urban places .......................................................... 75 67 83 5.9
Rural areas ...................................................................
. . . . . .
68 63 72 69 62 “’”76 7.3
Annual family income
Under $5,000 ............................................................... 124 139 113 85 114 170 9.7
$5.000.$9.999 .............................................................. 71 56 85 76 58 93 7.3
$10,000 and over ........................................................ 47 41 54 58 47 60 5.0
‘Includesotherracialgroups.
—
Table 9. Prevalence rates of eye pathology (actual and standardized) needing but not under medics/ treatment among the population 1=
years by race, geographic region, population size, and income, with selected standard errors United States, 1971-72 —
Eye pathology needing but not under medical care
Characteristic
—
Actual rates Standardized rates All ages,
Both sexes Males Females Both sexes Males Females both sexes
—
Race Rate per 1,000 population Standard error
All racesl ...................................................................... 34 34 35 . . . 4.2 “
White ......................................................................... 32 32 32 32 32 “i; 4.3
Black .......................................................................... 52 46 58 59 53 65 8.3
Geographic region
Nodheast ....................................................................... 30 25 35 30 25 34 4.9
Midwest ......................................................................... 34 34 34 35 35 35 13.2
South ............................................................................. 33 30 35 32 31 34 7.4
West ............................................................................... 39 46 33 40 47 35 5.5
Urban-rural
All urban places .......................................................... 40 37 42 . . 5.7
Rural areas ...................................................................
. . .
24 28 20 24 28 20 6.2
Annual family income
Under $5,000 ............................................................... 52 62 45 41 50 37 7.2
$5.000.$9.999 .............................................................. 32 30 35 34 28 38 5.3
$10,000 and over ........................................................ 27 27 28 27 27 29 5.6 —
‘includesotherracialgroups.
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Table 10. Prevalence rates of eye pathology, (actual and standardized) under medical care among the population 1-74 years by race,
geographic region, population size, and income with selected standard errors United States, 1971-72
Eye pathology causing vision decrease
Characteristic Actual rates Standardized rates A//ages,
Both sexes Males Females Both sexes Males Females both sexes
Race Rate per 1,000 population Standard error
All races’ ...................................................................... 36 31 41 4.7
White .........................................................................
. . . . . .
38 33 44 38 33 43 4.9
Black .......................................................................... 20 16 24 25 20 29 5.8
Geographic region
NoRheast ....................................................................... 36 29 42 35 28 40 6.4
Midwest ......................................................................... 34 34 34 35 34 36 14.4
South ............................................................................. 42 33 51 41 32 49 6.3
West ............................................................................... 33 28 38 34 29 38 6.5
Urban-rural
All urban pIaces .......................................................... 41 35 46 6.7
Rural areas ...................................................................
. . . . . .
28 23 33 28 22 33 4.3
Annual family income
Under $5,000 ............................................................... 36 29 42 26 18 29 7.2
$5.000.$9.999 .............................................................. 35 32 36 36 34 40 5.0
$10,000 and over ........................................................ 36 31 41 41 33 48 6.4
llncludes other racial groups.
Table 11. Prevalence rates (actual and standardized) of eye pathology causing decrease in vision, eye conditions needing medical treatment, and
those under medical care for eye conditions among adults 16-74 years of age by education level, with standard errors United States, 1971-72
Eye pathology causing vision decrease
Eye condition status and
years of schooling completed
Actual rates Standardized rates All ages,
Both sexes Males Females Both sexes Males Females both sexes
Condition(s) causing vision decrease
Education:
Less than 5 years .......................................................
5-8 years ......................................................................
9-12 years ....................................................................
13 years or more ........................................................
Condition(s) needing medical treatment
Education:
Less than 5 years .......................................................
5-8 years ......................................................................
9-12 years ....................................................................
13 years or more ........................................................
Condition(s) under medical care
Education:
Less than 5 years .......................................................
5-8 years ......................................................................
9-12 years ....................................................................
13 years or more ........................................................
Rate per 1,000 population
306 308 304 151 155 148
179 175 183 84 86 82
81 71 89 65 55 73
58 54 63 44 45 44
152 175 124 71 93 48
56 55 57 38 40 36
37 34 39 28 24 32
26 26 25 18 19 17
72 81 61 46 37 52
55 39 71 33 32 35
39 35 42 30 25 35
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The sampling design for the first National Health
and Nutrition Examination Survey (NHANES I),
conducted in 1971–74, was basically a three-stage
stratified, multistage probability sample of loose clus-
ters of persons in land-based segments. The sample
was designed to be representative of the civilian
noninstitutionalized population 1–74 years of age of
the coterminous United States. Excluded from the
selection were persons residing in Alaska and Hawaii
and those within the coterminous United States who
were confined to institutions or residing on lands set
aside for use by American Indians. Successive elements
dealt with in the process of sampling were primary
sampling units (PSU’S), census enumeration districts
(ED’s), segments (clusters of households), households,
eligible persons, and finally sample persons.
The starting points in the first stage of this design
were the 1960 decennial census lists of addresses and
the nearly 1,900 PSU’S into which the entire United
States was divided. Each PSU was either a standard
metropolitan statistical area (SMSA), a single county,
or two or three contiguous counties. The PSU’S were
grouped into 357 strata as they were for use in the
1963–72 National Health Interview Surveys and subse-
quently collapsed into 40 superstrata for use in the
NHANES I.
Of the 40 superstrata, 15 contained single large
metropolitan areas of more than 2 million population.
Those 15 large metropolitan areas were selected for the
sample with certainty. The 25 noncertainty strata were
classified into 4 broad geographic regions of approxi-
mately equal population and cross-classified into 4
broad population density groups in each region. Then
a modified Goodman-Kish controlled selection tech-
nique was used to select 2 PSU’S from each of the 25
noncertainty superstrata with the probability of selec-
tion of a PSU proportionate to its 1960 population so
that proportionate representation of specified State
groups and rate of population change classes was
maintained in the sample. In this manner a total first-
stage sample of 65 PSU’S was selected. These 65
sample PSU’S, or stands, are the areas within which
samples of persons would be selected for examination
over the 3–year survey period.
To produce national estimates of the nutritional
status of the U.S. population at an earlier date, a
probability subsample of 35 of the 65 stands was
selected. This 35–stand subsample also made it possi-
ble to produce national estimates of certain other
aspects of health status in the population that were
critically needed at an earlier date and estimates of the
findings for examination components that for logistic
reasons could not be continued for the remainder of
the 65 stands. Included among the 35 stands were 10
of the 15 large “certainty” metropolitan areas and 1
stand from each of the 25 “noncertainty” superstrata.
The reduction from 15 to 10 large metropolitan areas
was accomplished by randomly selecting one stand
from multiple-stand standard metropolitan statistical
areas (SMSA’S), e.g., selecting the southern half of the
Chicago SMSA to represent the entire SMSA. (This
selection procedure was based on operational consider-
ations, and although unbiased, is recognized as not
behg statistically optimal.) It is this subsample of 35
stands upon which the findings contained in this report
are based.
Although the 1970 census data were used as the
frame for selecting the sample within PSU’S when they
became available, the calendar of operations required
that 1960 census data be used for the 35–stand sample
of NHANES. Census enumeration districts in each
PSU were divided into segments of an expected six
housing units each. In urban EDs the segments were
clusters of six addresses from the 1960 census listing
books. For ED’s not having usable addresses, area
sampling was employed, and consequently some varia-
tion in the segment size occurred. To make the sample
representative of the then-current population of the
United States, the address or list segments were
supplemented by a sample of housing units that had
been constructed since 1960.
Within each PSU a systematic sample of segments
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was selected. The ED’s that fell into the sample were
coded into one of two economic classes. The first class,
identified as the “poverty stratum,” was composed of
“current poverty areas” that had been identified by the
U.S. Bureau of the Census in 1970 (pre–1 970 census),
plus other ED’s in the PSU with a mean annual
income of less than $3,000 in 1959 (based on the 1960
census). The second economic class, the “nonpoverty
stratum,” included all ED’s not designated as belong-
ing to the poverty stratum.
All sample segments classified as being in the
poverty stratum were retained in the sample. For those
sample segments in nonpoverty-stratum ED’s, the
selected segments were divided into eight random
subgroups, and one of the subgroups was chosen to
remain in the NHANES sample. This procedure
permitted a separate analysis with adequate reliability
of those classified as being below the poverty level and
those classified as being above the poverty level.
After identification of the sample segments, a list
of all current addresses within the segment boundaries
was made, and the households were interviewed to
determine the age and sex of each household member,
as well as other demographic and socioeconomic
information required for the survey.
For selection of persons in sample segments to be
examined in the National Health and Nutrition Exam-
ination Survey, all household members 1–74 years of
age in each segment were listed on a sample selection
worksheet, with each household in the segment listed
serially. The number of household members in each of
the six age-sex groups shown below was listed on the
worksheet under the appropriate age-sex group col-
umn. The sample selection worksheets then were put
in segment number order and a systematic random
sample of persons in each age-sex group was selected
to be examined using the following sample rates:
Age in years Rate
The persons selected in the 35–stand sample of the
Health and Nutrition Examination Survey comprised
a representative sample of the target population and
included 14,147 sample persons 1–74 years of age, of
whom 10,126, or 71.6 percent, were examined. When
adjustments are made for differential sampling for
high-risk groups, the response rate becomes 72.8
percent.
All data presented in this report are based on
weighted observations; that is, data recorded for each
sample person are inflated to characterize the subuni-
verse from which that sample person was drawn. The
weight for each examined person is a product of the
reciprocal of the probability of selecting the person, an
adjustment for nonresponse cases (i.e., persons not
examined), and a poststratified ratio adjustment that
increases precision by bringing survey results into
closer alignment with known U.S. population figures.
A more detailed description of the survey design
andl selection technique can be found in “Plan and
operation of the Health and Nutrition Examination
Survey, United States, 1971-1973,” Vital and Health
Statistics, Series 1, No. 10a.G
Ncmresponse
In any health examination survey, after the sample
is identified and the sample persons are requested to
participate in the examination, the survey meets one of
its more severe problems. Usually a sizable number of
sample persons will not participate in the examination.
Whether an individual participates is determined by
many factors, some of which are uncontrollable and
therefore may reasonably be treated as an outcome of a
random event with a particular probability of occur-
rence. In this situation the effect of nonparticipation
would be only to reduce the sample size, thereby
increasing the sampling errors of examination findings.
In practice, however, a potential for bias due to
nonresponse exists if participation is not random event
ancl if nonparticipants ditTer from participants. Be-
cause of the possibility of bias intensive efforts are
made in the National Health and Nutrition Examina-
tion Survey to develop and implement procedures and
inducements that would reduce the number of nonre-
spondents and thereby reduce the potential of bias due
to nonresponse. These procedures and inducements are
discussed in “Plan and operation of the Health and
Nutrition Examination Survey,” Series 1, No. 10a.G
Despite these intensive efforts, 27.2 percent of the
sample persons from the first 35 stands were not
examined. Consequently, the potential for a sizable
bias does exist in the estimates in this publication.
From what is known about the nonrespondents and
the nature of nonresponse, it is believed that the
likelihood of sizable bias is small. For instance, only a
small proportion of persons gave reasons for nonpartic-
ipation that would lead to the belief that they would
never agree to participate in examination surveys and
that they might have differed from examined persons
with respect to the characteristics under examination.
Only 15 percent of the nonrespondents gave as their
reasons for nonparticipation ‘Lpersonal illness,” “phys-
ically unable,” “pregnant,” “antidoctor,” or “feZLrof
finding something wrong.” Typical among the reasons
given by the other nonrespondents were “unable
because of work, school, or household duties”; “suspi-
cious” or skeptical of the program”; “just not interest-
NOTE: A list of references follows the text.
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ed in participating”; and “private medical care
sufficient” or “just visited doctor.”
An analysis of medical history data obtained for
most nonexaminees as well as examinees also supports
the belief that the likelihood of sizable bias due to
nonresponse is small. No large differences were found
between the examined group and the nonexamined
group in the statistics compared. For example, 11
percent of persons examined reported having an illness
or condition that interfered with their eating as
compared with 9 percent of persons who were not
examined but who had completed a medical history.
The proportion of persons examined who reported
ever being told by a doctor that they had arthritis was
20 percen~ the proportion for high blood pressure was
18 percent and for diabetes, 4 percent. The corre-
sponding proportions for nonexamined persons were
17 percent for arthritis, 21 percent for high blood
pressure, and 4 percent for diabetes.
As mentioned earlier, the data in this report are
based on weighted observations, and one of the
components of the weight assigned to an examined
person was an adjustment for nonresponse. A proce-
dure was adopted that multiplied the reciprocal of the
probability of selection of sample persons by a factor
that brought estimates based only on examined per-
sons up to a level that would have been achieved if all
sample persons had been examined. This nonresponse
adjustment factor is the ratio of the sum of sampling
weights for all sample persons within a relatively
homogeneous class defined by age, sex, and poverty
status to the sum of sampling weights for all respond-
ing sample persons within the same homogeneous
class. To the degree that homogeneous groups that are
also homogeneous with respect to the characteristics
under study can be defined, the procedure can be
effective in reducing the potential bias from non-
response.
For the 35-stand sample of the National Health
and Nutrition Examination Survey, persons were
grouped into 20 age-sex-poverty status groups within
each stand, yielding 700 separate cells with an average
membership of about 20 sample persons each. These
adjustment factors were distributed among examined
persons as shown in table I.
Table 1. Percent distribution of non response adjustment factors,
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Examination surveys are subject to the loss of
information not only through the failure to examine all
sample persons but also from the failure to complete
all examination components and to record the various
items of information needed for each of those who
come to the examining units.
The extent of missing data for the eye examination
ranged from 1.9 percent for those 18–24 years and
45–54 years to 3.6 percent of those 3544 years of age
(table II).
More data are missing among males than among
females (4 percent compared with 1 percent) and more
among nonwhites than among whites (5 percent
compared with less than 2 percent). Only among
nonwhite males ages 35-44 years and 25–34 years is
the loss sufficient to make the estimates for these
groups substantially less reliable than for the others. In
those two age groups, 32 percent and 20 percent,
respectively, of the eye examinations for nonwhite
males were not completed.
No imputation was made to replace missing eye
examination data. The assumption has been made here
that the distribution by age, sex, race, and other
variables of these findings relating to eye pathology
among persons with missing data is similar to that
among those who were examined.
Small numbers
In some tables, magnitudes are shown for cells for
which the sample sizes are so small that the sampling
errors may be several times as great as the statistics
themselves. In such instances the numbers, if shown,
have been included to convey an impression of the
overall story of the table.
Sampling and measurement error
This report has referred to efforts to minimize bias
and variability of examination methods and measure-
ment techniques. The potential of residual bias due to
the high nonresponse rate has also been discussed.
The probability design of the survey makes possi-
ble the calculation of sampling errors. Traditionally
the role of the sampling error has been the determina-
tion of how imprecise the results of a survey may be
because they come from the measurement of a sample
rather than all elements in the universe.
The estimation of sampling errors for a study of
the type of the National Health and Nutrition Examin-
ation Survey is difficult for at least three reasons: (1)
Measurement error and “pure” sampling error are
confounded in the data—it is not easy to find a
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Table Il. Number of examinees and number and percent of examinees not given eye examination, by age at examination, and number not
given eye examination by race and sex: lNational Health and Nutrition Examination Survey, 1971-72
Examination status, sex, and race
Age at examination
Al/ages, 1-5 6-11 12-17 18-24 25-34 35-44 45-54 55-65 (55-74
1–74 years years years years years years years yeara years years
Number
All examinees ............................................... 10,126 1,489 1,061 1,045 1,015 1,259 1,170 793 630 1,653
Examinees not given eye examination . 248 38 25 25 20 31 42 15 14 38
Percent
Examinees not given eye examination .... 2.4 2.6 2.3 2.4 1.9 2.4 3.6 1.9 2.2 2.3
Number
Male ............................................................ 171 22 16 15 15 24 30 10 8 31
Female ....................................................... 77 16 9 10 5 7 12 5 6 7
White ............................................................... 115 19 14 12 9 8 12 10 7 24
Male ............................................................ 85 12 10 8 7 7 11 6 4 20
Female .......... ................................ ........... 30 7 4 4 2 1 1 4 3 4
Black ............................................................... 133 19 11 13 11 23 30 5 7
Male ............................................................
14
86 10 6 7 8 17 19 4 4 11
Female ....................................................... 47 9 5 6 3 6 11 1 3 3
procedure that will either completely include both or
treat oneorthe other separately; (2)the survey design
and estimation procedures are complex and, accord-
ingly, require computationally involved techniques for
the calculation of variances; and (3) hundreds of
statistics are presented in the tables in this report,
many for subclasses of the population for which there
were small numbers of sample cases. Estimates of
sampling error are obtained from the sample data and
are themselves subject to sampling error, which may
be large when the number of cases in a cell is small or,
occasionally, when the number of cases is substantial.
Estimates of the standard errors for selected
statistics used in this report are presented in the
detailed tables. These estimates have been prepared by
a replication technique that yields overall variabilityy
through observation of variability among random
subsamples of the total sample. The standard error is
primarily a measure of sampling variability, that is, of
the variations that might occur by chance because only
a sample of the population has been surveyed. As
calculated for this report, the standard error also
reflects part of the variation that arises in the measure-
ment process. It does not include estimates of any
biases that might exist in the data, The chances are
about 68 out of 100 that an estimate from the sample
would differ from a complete census by less than the
standard error. The chances are about 95 out of 100
that the difference would be less than twice the
standard error and about 99 out of 100 that it would be
less than 2 1/2 times as large.
Tests of significance
The procedure used in this report for testing the
significance of the difference between two rates or
percents consisted of dividing the difference between
the two rates by the standard error of the differenc~
that is, a z statistic was computed. An approxim~ation
of the standard error of a difference d = x — y alftwo
statistics (rates, percents or other) x and y is given by
the formula
in which S%and Sy are the sampling errors respective-
ly, of x and y. If the two groups or measures are
positively or negatively correlated, the formula gives
an overestimate or underestimate, respectively, c~fthe
actual standard error. A 95–percent confidence limit
has been used in the text, i.e., z = d/& < 1.96.
Patterns of dtierences or consistent trends in which
the differences are not large enough to be statistically
significant are referred to as “observed.”
Examiner variability
Supervised examinations and testing with ~some
measurement replication were done by the senior
ophthalmologists from NEI at 24 of the 35 examina-
tion locations for approximately 2.5 percent of the
9,878 persons given the complete eye examination.
This close supervision of the actual examination was
done at the first two sessions at each of the 24
examination locations.
Additional training in the ophthalmology exami-
nation protocol had been given each ophthalmologist
before the survey examinations were started. In addi-
tiom, the senior ophthalmologists reviewed the meth-
ods used and the findings recorded by the 96 oph,thal-
malogists employed during the survey. After comple-
tion of this part of the NHANES survey, there was a
complete review of the findings and diagnoses of eye
conditions under protocol established by Dr. Ganley
and others at NEI.
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The number of examinees per ophthalmologist
examiner ranged from 3 to 50, with 30 percent
examining fewer than 50 persons, 29 percent 50-99
persons, 31 percent 100-199 persons, and 8 percent
200 persons or more. Variation would be expected
among examiners in the proportion of their examinees
found to have significant eye pathology because of
differences in age-sex distribution among the groups
examined, area differences, hereditary differences, the
extent and type of environmental exposure that may
affect the eyes, and other factors. So the extent of
examiner variability and the effect that it may have
had on the findings from this ophthalmology examina-
tion may be assessed, the effect of age-sex d~erences in
the groups examined by each ophthalmologist has been
controlled through a direct adjustment method. In this
method the age-sex specific rates for each examiner
have been applied against the number of persons in
that age-sex group for the total population and the age-
sex adiusted rate recomputed.
Among
proportions
persons e;amined, the age-sex adjusted
found to have significant eye pathology
range from 6.6 to 83.5 percent per examiner, with one-
fourth of the ophthalmologists finding 27.4 percent or
fewer of the examinees to have such pathology, one-
half finding between 27.4 and 48.0 percent and the
remaining one-fourth finding 48.0 percent or more
with significant eye pathology (table III).
A further assessment of examination location
differences that may affect the prevalence of eye
pathology as determined in this study shows that the
number of examinees given the eye component ranged
from 112 to 539 per stand. The age-sex adjusted
prevalence rates for significant eye pathology ranged
from 18.8 percent to 63.0 percent among the 35
examination locations. In one-fourth of the locations,
32.1 percent or fewer of the examinees were found to
have significant eye pathology, one-half showed be-
tween 32.1 and 43.6 percent, and the remaining one-
fourth 43.6 percent or more (table IV).
These tables show very large variations in eye
pathology rates by examiner and examination location,
reflecting both variation in the occurrence of such
conditions in the population and examiner variability
that cannot be separated in the data available.
Table IIl. Number of examinees and age-sex-adjusted proportions with eye pathology, by ophthalmologist examiner number
NHANES, 1971-72
Examiner number
Eye pathology rate Number
Examiner number
Eye pathology rate Number of


























































































































































































































Table Ill. Number of examinees and age-sex-adjusted proportions with eye pathology, by ophthalmologist examiner numbec
NHANES, 1971-72-Con.
Examiner number
Eye pathology rate Number
per 1,000 persons examinees
Examiner number
Eye pathology rate Number of




















































Table IV. Number of examinees and age-sex-adjusted proportion of
examinees with eye pathalogy, by examination location: NHANES,
1971-72
Examination location number
Eye pathology Number of













































































Examination prior to dilatation
Ocular history.—The ophthalmologist examiner
asked each exarninee whether the examinee had ever
had problems (excluding refraction) or diseases of the
for which he or she had seen a physician, and eye
specialist, or an optometrist and, if so, what the
problem was (figure I).
Pupils.—The presence of anisocoria was recorded,
along with the measurement in millimeters of the
diameter of the pupils in both eyes if their diameters
differed by more than 1 mm.
The absence of direct light reflex was determined
in a normally lighted room by the examiner directing
the beam of a Finoff ocular transilluminator directly
into the examinee’s eyes from a distance of approxi-
mately 3 inches and observing pupillary contraction
while the examinee was fixating at distance. The
examiner determined the absence of consensual light
reflex by observing the pupillary response in the
unstimulated eye.
Lids.—The examination of the lids was done by
gross examination, using a Finoff hand illuminator in a
fully illuminated room, followed by slit lamp evalu-
ation of the lid margins under low magnification.
Globe.—For suspected conditions of exophthal-
mos, the actual Hertel measurements and the base
used were recorded for later review. For suspected
conditions of microthalmus, the horizontal corneal
diameter from external limbus to external limbus was
measured for later review.
Conjunctiva.—The conjunctival were examined by
gross inspection under the low magnification of the slit
lamp.
Cornea.—The cornea was screened under the low
magnification of the slit lamp; abnormalities found
were then examined under higher power.
Anterior chamber.—The anterior chamber was
examined for flare with the small dot of light from the
slit lamp directed toward the pupil at about a 60°
angle.
Iris.—The iris was examined under the lower
power of the Zeiss microscope. The examiner evalu-
ated evidence of atrophy of the iris by directing the
light beam through the pupil into the posterior
chamber and looking for transmission of light through
the iris tissue. Gonioscopy was used to confirm
conditions of peripheral anterior synechiae when
suspected.
Tonometry.-Applanation tonometry was per-
formed on all individuals ages 2CP74 years. When it
was necessary to hold the lids open for tonometry
because of lid-squeezing reflex or when the upper lid
rested on the tonometer with any degree of pressure
during the measurement, the test was recorded as
unsatisfactory because either may artificially elevate
intraocular pressure to give a falsely high reading.
The Goldman applanation tonometer used for this
procedure was mounted on a Zeiss slit lamp. Intraocu-
lar pressure measurements were made soon after the
installation of 0.1 percent fluorescingin the eyes. Three
readings, obtained under magnification of 8-1 OX, were
taken in each eye consecutively starting with the right.
The tonometer was repositioned for each reading after
the measuring scale had been turned to 10 mm Hg.
The slit illuminating aperture was opened fully and
positioned at about a 60° angle to the slit lamp with
the prism in contact with the cornea. The position was
corrected so that the two semicircles were of equal si~e
and in the middle of the field of view. The measuring
drum in the tonometer then was turned until the inner
borders of the two fluorescingrings just touched each
other (the midpoint of each pulsation of the eye); the
pressure from the drum was recorded to the nearest
mm Hg.
Dilatation
Before dilatation the examinee was asked about
symptoms compatible with attacks of acute narrow-
angle glaucoma including transient blurring of vision
associated with ocular pain or frontal headaches.
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The examinee checked the depth of the anterior
chamber before dilatation by directing the slit beam of
the illuminator at about 60° toward the anterior
chamber just inside the lumbus. If the separation was
slitlike, or less than one-fourth the corneal width,
gonioscopy was used to rule out the possibility of angle
closure or symptoms suggestive of angle closure. The
angle at the narrowest area in each eye was recorded
for further review.
Dilatation was not done if the angle of closure was
found to be 10° or narrower in any area. Dilatation for
all other examinees was done with a solution of 1
percent mydriacyl unless the person was 50 years of
age or younger, was hyperopic without corrective
lenses and would be driving immediately after the
examination. For this latter group a solution of 10
percent phenylephrine was used.
Twenty to 70 minutes after dilatation, the examin-
ee was returned to the ophthalmologist for the remain-
der of the eye examination. The examiner then
recorded whether the dilatation at that point was
adequate for the fundus evaluation.
Eye examination after dilatation
Lens.—The crystalline lens was evaluated with the
slit lamp and then with a direct ophthalmoscope (+10
lens). Only opacities observed by both instruments
were recorded unless there was evidence of nuclear
sclerosis (decreased lucency of the nucleus recorded as
nuclear opacity) on the slit lamp evaluation.
Retina. —Goldman or Hruby lenses were used in
the examination of the fundus only if pathology was
suspected. The indirect ophthalmoscope was not used
for routine examination of the examinee because
dilatation was not uniformly adequate for evaluation
of the periphal retina and because the examiners were
not equally proficient in the use of the instrument.
Ophthalmic diagnosis
The ophthalmologists recorded their diagnostic
findings as abnormal if any physiologic or pathologic
changes were found during the course of the eye
examination. Not classified as abnormal were findings
limited to refractive error, phoria, arcus senilis, benign
melanosis, concretions, pingueculum, inclusions. or
follicles. If a refractive error was associated with
other ocular pathology, such as myopia, Fuchs’ spot,
or peripheral retinal degeneration, the finding was
classed as abnormal.
Diagnostic entities were recorded under this sec-
tion rather than under the checklist of findings on
which the diagnosis was based as shown in the detail of
the eye examination. If the physiologic or pathologic
changes found in the eye were not part of a more
general diagnosis, they were listed in the diagnostic
section. If the lens, cornea, extraocular muscles,, etc.,
had become involved in the diabetic process, in
addition to the diagnosis of diabetic retinopathy, those
related conditions would also be listed separately as
cataract secondary to diabetes mellitus, iris neovascu-
larization secondary to diabetes mellitus, etc. Refrac-
tive error associated with other ocular pathology, such
as myopia and Fuchs’ spots or peripheral retinal
degeneration would have been shown as the appropri-
ate diagnostic entity of degenerative, pathologic, pro-
gressive, or malignant myopia. Etiology identification
was included on the diagnoses wherever possible.
Amblyopia was diagnosed if vision could not be
corrected to 20/30 or better and resulted from a
strabismic or anisometropic condition (the difference
in refractive error between the two eyes) but not if the
loss of vision was due to other causes.
Up to 11 diagnoses were recorded for each
examinee with abnormal eye pathology. The most
serious conditions—those that needed treatment and
those that caused decrease in visual acuity–-were
listed first.
For each diagnostic entity the examiner indicated
whether the condition contributed to transient or
permanent decrease in distance vision (any vision
worse than 20/20 in the involved eye). The examiner
also indicated for each diagnosis whether treatment
was needed but not being received, treatment was
needed and was being received, or treatment was not
needed.
Conditions were considered as needing treatment if
the examiner concluded during the examination that
treatment should be provided. For example, an exam-
inee with narrow angles would not be considered to
require treatment, while one with occluded angles
would. An adult with divergent strabismus would not
be considered to require treatment even though cos-
metic surgery might be beneficial. An examinee with
cataracts and 20/40 vision would not be deemed in
need of surgery, whereas one with cataracts and
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z. Deck No. b. Sample No. c. Sex d. Age ●. Examiner No. f. Name of examiner
162 __. ––
t ❑ Male
2 ❑ Female —— ——
I
A. SIGNIFICANT OCULAR HISTORY ~ @ lUYes
I 20N0
1. Surgery - ❑ Strabismus ❑ Cataract
i @ ------
2. Other - ❑ Iniury ❑ Infection
i@------





B. VISUAL ACUITY I
l. Optotype used, . . . . . . . . . . . . . . . . . 1. ~ @ I ❑ Snellen
I
I 2D Ill. E
I
2. Acuity cc OD 2. ~ (@- —
0s ,0~m7 *__
sc OD : @*--
0s ~@iil*--
3. If not 20/20, pinhole (Acuity) . . . . . . . . 3. /
OD ! @l*--





l. Tropia . . . . . . . . . . . . . . . . . . . . . . . .
:
1. I @ IDESO 2 ❑ Exo 3 ❑ Neither
: @ I ❑ Hyper
i
2 ❑ Not hyper
,_ o~014 I ❑ Comitant 2 ❑ Incomitant-----------------------------------------
2. Phoria . . . . . . . . . . . . . . . . . . . . . . . 2.1 @ IOESO 2 ❑ Exo 3 ❑ Neither
~ @ t ~ Hyper 2 ❑ Not hyper
------------------------------------------
3. Nystegmus . . . . . . . . . . . . . . . . . . . . 3. \ @ I ❑ Pendular 4 n Jerk-rotq
I













D. PUPILS I C)D 0s Ou
I
1. Anisocoria - location. . . . . . . . . , . . . 1. ~@ 1[3 20 3U
a. -(mm) . . . . . . . . . . . . . . . . . . a.! ——
2. Absent Ii ght reflex
I
a. Direct . . . . . . . . . . . . . . . . . . . 2a. l@ 1[~ 2= 3D
b. Consensual . . . . . . . . . . . . . . . . b.@ 1[~ zl_J 30
I
3. Other – Specify I
3. I@ 1[3 20 30
4. No abnormal icy . . . . . . . . . . . . . . ...4. / 1 [3 20 30
I






Time of test p.m. ~ @ _,_ o024 _ _
❑ Unsatisfactory test
(Code 99 in space 023) @-- 0026 _ _
‘o/027 _. _ o028 _ _
—
I
Anterior segment check prior to dilatation.
-
~ @ 1 ~ NOt dilated:
—
F. DILATATION
(I gtt. 10% Phenylephrine OU)
a Suspicious anterior chamber
❑ History of angle closure
❑ Unable to instill gtts.
I
I 2 ❑ Mydriasis inadequate for fund us copy
I
3 n Di Iatation adequateI
H. MAXILLARY SINUS TRANSILLUMINATION !
l. Right . . . . . . . . . . . . . . . . . . . . . . 1. ~ @ l13Normal 2~Dull 3 ❑ Opaque
2. Left . . . . . . . . . . . . . . . . . . . . . . . 2. ~ @ I ❑ Normal 20 DuII 3 ❑ Opaque
I
NOTES
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. REFRACTION Eye Sphere Cylinder Axis VA PH
@ cwJ O& OXIJ (IWJ
1. Present glasses OD 10+ 10+
2D - ——.—— D 2u - __, __EI ___”
040J 041J C@ 043J 044J
0s 10+ 10+
2a- __. __D 2n - __. ——D ———
0
O&J C14t5J 047J 048J 049J 050J 051J
2. If acuity less than OD 10+ 10+
20/40, retinoscopy 2!7J - __. _— D 2u - __. __D _——” c*—— c.*__
I152J 053J 054J 055J 05ifJ 057J Ox?J
0s 10+ 10+ — .
*To be entered by coder
o
2n - __. __D 2a- __. ——D ——— c*—— c*__
1. LIDS 0s Ou
l. Blepharitis . . . . . . . . . . . . . . . . . . . . . . . . 1. :@l: Zn 3U
a. Angular . . . . . . . . . . . . . . . . . . . . . . . . a.~@ll_J ZU SU
2. Chalazion . . . . . . . . . . . . . . . . . . . . . . . . . 2.~@ln 20 30
3. Concretions . . . . . . . . . . . . . . . . . . . . . . . 3. @ln 20 SD
4. Ectropion . . . . . . . . . . . . . . . . . . . . . . ...4. ~@ln 21-J ,~
5. Entropion . . . . . . . . . . . . . . . . . . . . . . . . . 5./@l~ 20 30
6. Hordeolum . . . . . . . . . . . . . . . . . . . . . . . . 6.@l D 20 30
7. Ptosis . . . . . . . . . . . . . . . . . . . . . . . . . . . 7.~@la 20 30
I
8. Other – Specity I
/
8.@lD 2D 30
9. No abnormal icy . . . . . . . . . . . . . . . . . . . . . 9.@ln 20 30
(. GLOBE I OD 0s Ou
I
l. Enucleation . . . . . . . . . . . . . . . . . . . . . . . l.~@l c-J 2CI 3D
2. Exophthalmos . . . . . . . . . . . . . . . . . . . . . . 2.: @l-J 20 3CI
I
a. Measurement . . . . . . . . . . . . . . . . . . . a. II
b. Base . . . . . . . . . . . . . . . . . . . . . . . . b. :
I
3. Microphthalmos . . . . . . . . . . . . . . . . . . . . . 3.~@ln 2 !-J Sm
I
a. Measurement (mm) . . . . . . . . . . . . . . . a, I
4. Other–Specify
4.:@l D 2 L:] 30
I
5. No abnormality . . . . . . . . . . . . . . . . . . . . . 5.~@lD 20 3n
I





-- CONJUNCTIVA OD 0s Ou
I
l. Bitot’s spot . . . . . . . . . . . . . . . . . . . l.l@ln 20 30
2. Conjunctivitis
I
a. Allergic . . . . . . . . . . . . . . . . . ~a.~@ln 20 30
b. Follicular . . . . . . . . . . . . . . . . bj @10 ZU 30
c. in factious . . . . . . . . . . . . . . . . . .o~@ln 20 30







(2) Viral – Specify7 I
I
(2)1 @ In 2U 3n
I
3. Follicles (no inflammation). . , . . . . . . . 3’. ~@l c-J 20 30
4. inclusions . . . . . . . . . . . . . . . . . ...4. !@IO ZU 3D
5. Pingueculum . . . . . . . . . . . . . . . . . . . 5’. @ln 20 30
6. Xerosis . . . . . . . . . . . . . . . . . . . ...6. @lD z~ 3~








l. Ectasia . . . . . . . . . . . . . . . . . . . . . . l.i@ln 20 3D
2. Episcleriti s . . . . . . . . . . . . . . . . . . . 2.~@l(g 20 3D
I
3. Scleritis . . . . . . . . . . . . . . . . . . . . . 3.~@ln 20 30
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Arcussenilis . . . . . . . . . . . . . . . . . . l.po 2U
Band keratopathy . . . . . . . . . . . . . . . 2.~@la 2D









a. Epithelial . . . . . . . . . . . . . . . . 5a.~ @l 1 ❑
b. Stromal, . . . . . . . . . . . . . . . . b.@~~
Endothelial KP’s . . . . . . . . . . . . . . . 6.@lD





Keratomalacia . . . . . . . . . . . . . . . . . 9.; (@la
I
Krukenberg spindle . . . . . . . . . . . . . . lo.~@la
I
Opacity - Specify I
11. ~@lm 20
0. Superficial stromal . . . . . , . . . . . . ..~@l~ 2~
Pterygium . . . . . . . . . . . . . . . . . . . . 12. @lcl 20
I






No abnormal icy . . . . . . . . . . . . . . . . . 15. \@la



















Diagram location of abnormalities . . . . 16. ~
O. ANTERIOR CHAMBER
I
I 0“ 0s Ou
1. Cells . . . . . . . . . . . . . . . . . . . . . . . L~@ln Zn 30
2. Flare . . . . . . . . . . . . . . . . . . . . . . . 2.@l~ 20 3n




4. Noabnori,!ality . . . . . . . . . . . . . . . . . 4.l@ln 21-J 3EI
Figure 1. Detailed ophthalmology examination coding sheet, National Health and Nutrition Examination Survey, 1971-72-Con.
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I
P. IRIS I OD 0s Ou
1. Synechiae
a. Anterior . . . . . . . . . . . . . . . . . . la.~@lD 2!7 30
I
b. Posterior . . . . . . . . . . . . . . . . . b.~@la 20 3U
2. Atrophy . . . . . . . . . . . . . . . . . . . ...2. i@lcl 2~ ,~
3. Coloboma . . . . . . . . . . . . . . . . . . ...3. ~@trJ 2~ ,~
4. lritis . . . . . . . . . . . . . . . . . . . . . ...4. [ @ II-J 21’--J ,~
5. Neovascularization . . . . . . . . . . . . . . . 5. \ @ II-J ,~ ,~
6. Other-Specify I
& ~ @ In 2Q 30
7. No abnormality . . . . . . . . . . . . . . . . . 7. I @ In 20 30
~
Q. LENS
1. Aphakia . . . . . . . . . . . . . . . . . . . . . +2)1: 2: 3:
2. Cataract
a. immature . . . . . . . . . . . . . . . . 2a. \@ln 2U 3CI
b.lntumescent . . . . . . . . . . . . . . b.;@lU 20 3U
c. Mature . . . . . . . . . . . . . . . . . . ..\@ 10 20 30
d. Hypermature . . . . . . . . . . . . . . d.~@ln 20 30
e. Morgagnian . . . . . . . . . . . . . . . e.! @lD 21_J 3~
3. Opacity
a. Anterior polar . . . . . . . . . . . . . 3a.~@l~ 2D 30
b. Cortical . . . . . . . . . . . . . . . . b.@la 2D 30
c. Nuclear . . . . . . . . . . . . . . . . . ..~@ln ,~ ,~
d. Post subcapsular. . . . . . . . . . . d.@)ln 2D 31--J
I
4. Pigment on surface . . . . . . . . . . . . . . 4.;@l= 2U 30
I
5. Other - Specify I
5.\@l E3 20 3U
6. No abnormality . . . . . . . . . . . . . . . . . 6./@IU 20 30
1
R. VITREOUS I 0s Ou
l. Detachment . . . . . . . . . . . . . . . . . . . 1. & 2D 3D
2. Hemorrhage . . . . . . . . . . . . . . . . . . 2.@J1n 20 30
I
3. Opacity - Specify
I
3.~@lD 20 30




5. No abnormal icy . . . . . . . . . . . . . . . . . 5.~@ln 2U 30
I






Drusen . . . . . . . . . . . . . . . . .
Glaucomatous cup . . . . . . . . .
Neovascularization . . . . . . . . .
Optic atrophy
(l) Primary . . . . . . . . . . .
(2) Secondary . . . . . . . . . .
Papilledema . . . . . . . . . . . . .


























(l) Senile . . . . . . . . . . . .
(2) Disciform . . . . . . . . . .
(3) Circinate . . . . . . . . . .
Diabetic involvement . . . . . . .
Edema . . . . . . . . . . . . . . . . .
Hypertensive involve . . . . . . .























Branch occlusion , . . . . 3a(1)
. . . . (2)
. . . . (3)
. . . . (4)
. . . . b(1)
. . . . (2)
Central occlusion .
Gen. narrow ( 14).
Sclerosis ( 1-4) . .
Branch occlusion .
Cerltral ucclusion .





Sausaging . . . . . . . . . (4)
Sheathing . . . . . . . . . . (5)






(1) Microaneurysms . . . . . . c(1)
(@n(2) Neovascularization. , . . (2)
d. Other - Specify
d.
Figure L Detailed ophthalmologyexamination coding sheet, National Health and Nutrition ExaminationSurvey, 1971-72-Con.
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I
S. RETINA - Continued I
4. Exudates
o. Cotton wood . . . . . . . . . . . . . 4a. !@l:
b. Hard, . . . . . . . . . . . . . . . . . b. l@lcl
c. Waxy . . . . . . . . . . . . . . . . ..ea
~@L5
d. Other - Specify I
~. pu
!5. Hemorrhages
o. Choroidal . . . . . . . . . . . . ...5..
i@ln
b.preretinal . . . . . . . . . . . . . . b,,
!@ ’In
c. Retina l. . . . . . . . . . . . . . . . .
(l) Deep . . . . . . . . . . . . . c(1) ~ @ ‘1❑
(2) Superficial . . . . . . . . . (2)\@’in
d. Other - Specify I
d. !@m
6. Pigment changes
a. Choroidal . . . . . . . . . . . . . . . 6a. f@l~
b. Epithelial
(l) Atrophy . . . . . . . . . . . . b(l) @jl U
(2) Hyperplasia . . . . . . . . . (2)~@lD
I
c. Other - Specify
I
7. Angioid streaks . . . . . . . . . . . . . . . 7. @l~
8. Detachment . . . . . . . . . . . . . . . . . . 8m @l~
9. Drusen . . . . . . . . . . . . . . . . . . ...9.,
@ln
10. Inflammation




(l) Active . . . . . . . . . . . . . . . . . (l)l@ln
(2)lnactive . . . . . . . . . . . . . . . . (2)@lcl
11. Retrolental fibroplasia . . . . . . . . ...11. @lrJ
12. Other – Specify
I
12. @J1~
13. No abnormality . . . . . . . . . . . . . ...13. M@n
14. Not visual iced . . . . . . . . . . . . . ...14. @K2
Continue with item /5, Diagram location of
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I
S. RETINA - Continued/
15. Diagram
Iocati on of












DIAGNOSIS ~ (@ f ❑ Incomplete examination
2 ❑ No abnormalityI
3 ❑ AbnormalityI
Mark column applicable, leave blank if unknown




vision needed OD 0s Ou
g WJ lMJ 196
1. Amblyopia . . . . . . . I ❑ Present
1 ❑ Yes
2DN0 In 2U 3@
2H1~ _ 3 (-’-J
2. @ W&J 199 200
1 l_J Yes
2DN0 lU 2D 30——— .—. 10 Zn 3D
3. 201 202 2@3 204
1 m Yes
2DN0 In 2U 3U——— ——— m 2r--J3CI
L 2(MJ 206J q g
1 ❑ Yes
——— ——. 2DN0 10 2G 3D 17 2C 3~
;. g 210J 211 212
1 n Yes
2DN0 ~u 2D 3n——— ——— In 2C 3P
i. 213 214 y 216
I m Yes
2~No lU Zn 3D——— ———
la 2B 3D
JOTES
Figure L Detailed ophthalmology examination coding sheet, National Health and Nutrition Examination Survey, 1971-72-Con,
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Appendix Ill. Diagnosed
eye conditions by type,
site, and etiology
These prevalence data from the complete 6-digit N El medical care within broader groupings shown in the
Ophthalmic Disease Code adapted for N HAN ES 1 are findings and detailed tables of the report. They include
included solely to give some better idea of the extent to conditions identified in at least 10persons and all conditions
which the individual eye conditions were found and their causing vision decrease. needing (but not under) medical

















Rates per 1,000 population
Amblyopia (no code) 257 25.0 19.1 2.7 6.1
61. REFRACTIVE ERROR
Changes, myopic (central) (macular);
Conus, disc, myopic (atrophic) (choroidal) (chorioretinal) (peripapillary);
Myopia NOS
Myopia, simple;
Myopic changes (atrophic) (peripapillary) (temporal);
Myopic conus (atrophic (peripapillary) (temporal);
Myopic crescent (atrophic) (peripapillary) (temporal);
Myopic cup
Myopic disc (atrophic) (peripapillary) (temporal);
Myopic pigment atrophy, (choroid) (epitheliums);












Mass, eyelid (soft) (subcutaneous);
Nodule, eyelid;
Papule, eyelid;
Pigment, eyelid (area) (lesion);
Scar, eyelid NOS
Swelling, eyelid NOS
42 4.6 0.2 0.3
17 1.4 0.3 0.0
2 0.1 0.1
6 0.9 0.2



































Anomaly, congenital, eyelid, type specified NEQ
Distichiasi%
Epicanthus, in Mongolism (fold);
Epicanthus, absence of (fold);
Fold, epicanthal, in Mongolism;
Notch, eyelid, congenital
Blepharitis NOS (acute) (chronic) (subacute);
Granulated eyelid
Blepharitis, bacterial, organism specified NEC (acute) (chronic) (subacute);
Blepharitis, staphylococcal (acute) (chronic) (subacute)
Blepharitis, infective, organism not specified (acute) (chronic) (subacute)
Blepharitis, angular (acute) (chronic) (subacute)
Blepharitis, seborrheic (acute) (chronic) (marginal) (simple) (squamous)
(subacute)
Blepharitis, seborrheic, staphylococcal (acute) (chronic) (squamous)
(subacute)
Blephantis, sebaceous (acute) (chronic) (subacute);











Hemangioma, eyelid (benign) (strawberry);
Mole, eyelid (benign) (epidermal) (pedunculated) (pigmented);
Nevus, eyelid (benign) (compound) (dermal) (intraderrnal) (margin)
(pigmented) (strawbeny);
Papilloma, eyelid (epidermal) (pigmented) (squamous);
Syringoma, eyelid (benign);
Tumor, eyelid, benign










~:n~did NOS (epidermal) (epithelial) (inclusion) (sebaceous) (Zeiss
Milia, Milium, eyelid


































































































Absent eyelashes (area) (complete) (partial) (self-induced);
Angioma, spider, eyelid;
Cilia, aberrant
Cafe au Iait spot (area), eyelid;





Keratosis, eyelid (sebaceous) (seborrheic) (senile);
Lagophthalmos (eyelid);






Verruca, eyelid (plana) (vulgaris);
Wart, eyelid









Dilation, Dilatation, conjunctival, vessel;






Injection, conjunctival (due to upper respirator infection);








Vasodilation, conjunctival (red eyes);
Vascularization, conjunctival
Bleb, conjunctival, traumatic (filtering);
Trauma, conjunctival NEC or NOS
Adrenochrome granules, conjuncthq
Injection, conjunctival, pharmacologic
Conjunctivitis NOS (acute) (angular) (chronic) (follicular) (purulent)
(subacute);
Inflammation, conjunctival NOS (acute) (chronic) (subacute) --See also
Conjunctivitis
Conjunctivitis, bacterial, organism not specified (foilicular) (infection)
(infective) (acute) (chronic) (purulent) (subacute);
















































Conjunctivitis, staphlococcal (acute) (chronic) (purulent) (subacute);
Conjunctivitis, bacterial, organism specified NEC (acute) (chronic) (purulent)
(subacute); infection, conjunctival, bacterial, organism specified NEC (acute)
(chronic) (purulent) (subacute)
Conjunctivitis, rickettsial, organism not specified (acute) (chronic) (infection)
(infective) (subacute);
Conjunctivitis, viral, type not specified (acute) (chronic) (follicular) (infection)
(infective) (subacute);
Infection, conjunctival, rickettsial, organism not specified (acute) (chronic)
(subacute);
Infection, conjunctival, viral, organism not specified (acute) (chronic)
(subacute)
Conjunctivitis, infective, organism not specified (follicular) (acute) (chronic)
(purulent) (subacute);
Infection, conjunctival, organism not specified (acute) (chronic) (purulent)
(subacute)
Allergy, conjunctival NOS
Allergy, conjunctival, other than that due to medicinal drops or ointment
(acute) (chronic) (follicular) (subacute) (vernal]
Catarrh, Iimbal vernal;
Conjunctivitis, due to hay fevev
Conjunctivitis, allergic, other than that due to medicinal drops or ointment
(acute) (chronic) (follicuiar) (subacute) (vernal);
Injection, conjunctiya, allergiq
Injection, conjunctival, due to hay fever
Hemangioma, conjunctival (benign);
Lipoma, conjunctival









(fluid filled) (inclusion) (lymphatic) (Iymphoid)
66. EYEBALL
Asymmetry, one higher than other (facial);
Eye higher than other ey~





Anophthalmos, surgical, following inju~
Absent eye, postoperative, following inju~





































2 0.3 - 0.0
10 1.1 0.4 0.1
7 0.7 0.7



































Erosion, cornea (epithelial) (superficial);




Pigment, cornea (area) (deposit) (Descemet’s) (dust) (endothelial) (epithelial)
(granules) (Iimbus) (posterior) (scattered). If recorded under Opacity, code
as Opaci@
Stain, Staining, cornea (punctate) (superficial);
Wrinkle, Descemet’s membrane
Defect, cornea, due to trichiasis (epithelial)
“Other” checked, not described, cornea
Anomaly, congenital, cornea, type specified NEQ
Embryotoxon, posterior, cornea (prominent Schwalbe’s line);
Megalocornea
Macrocorne@
Myelinated nerve fibers, cornea
Schwalbe’s line, prominent
Keratitis (acute) (chronic) (inactive) (interstitial) (punctate) (stromal)
(subacute) (superficial)
Infection, cornea, bacterial, organism specified NEC (acute) (chronic)
(subacute);
Keratitis, due to leprosy (interstitial);
Keratitis, bacterial, organism specified NEC (acute) (chronic) (punctate)
(subacute)
Ulcer, cornea NOS
Abrasion, cornea, due to contact lens (epithelia);
Edema, cornea, due to contact lens (epithelial);
Keratitis, punctate, due to contact lens
Foreign body, cornea NOS (intracorneal) (metallic)
Stain, Staining, cornea, due to foreign body
(stain, staining);
Foreign body, cornea, retained





Dystrophy, Fuch’s (cornea) (endothelial) (epithelial) (senile)




Degeneration, cornea, marginal (senile)
Degeneration, cornea, peripheral (senile)
Degeneration, cornea, Iimbal (Iipoidal)
Pterygium, cornea
Opacity, cornea, surgical, due to removal of pterygium;













































































of ‘eta’ Causing Needing Under
Ophthalmic disease code

























Dry eye syndrome (dellen);
Degeneration, cornea, due to drying (dellen);
Degeneration, cornea, due to deficient tears (dellen)
Keratitis sicca NOS (punctate)
Krukenberg spindle
Pannu%
Vessels, cornea (blood) (deep) (Iimbal arcade) (superficial);
Vascularization, cornea
Pannus, traumatic
Opacity, cornea, due to foreign body (endothelial) (epithelial) (pigment)
(stromal) (superficial}
Opacity, cornea, metallic (like}
Rust lesion, pigmentation, ring, scar, or stain, cornea (stroma) (superficial)
Opacity, cornea, due to bum, acid (chemical) (endothelial) (epitheiial)
(pigment) (stromal) (superficial)
Opacity, cornea NOS (disciform) (endothelial) (epithelial) (Iimbus) (linear)
(microcysts, epithelial) (pigment) (stromal) (superficial);
Opaque cornea
Opacity, cornea, due to keratitis (exposure) (marginal) (stromal)
Opacity, cornea, due to old or healed ulcer
Opacity, cornea, due to syphillis (ghost vessels)
Opacity, cornea, due to trauma NEC or NOS (endothelial) (epithelial)
(lacerating) (Iimbus) (pigment) (stromal) (superficial)
Opacity, cornea, due to contact lens (epithelial) (punctate)
Bulls, cornea (epithelialk
Disease, cornea, type specified NEG
Ectasia, come%
Edema, cornea, (epithelial) (stromal~
Girdle, fimbal (cornea) (white);
Gkdle of Vogt (cornea) (Iimbusk
Hodson-Stahli line (pigmentation)
KP’s (endothelial) (pigment -cd);
Keratitis, bullous
Keratopathy, bullous
Opacity, Iimbal girdle (cornea) (white]
Precipitates, keratic (pigment -cd);
Precipitates, endothelial (pigment -cd);
Wait-Beetham lines
Edema, cornea, due to bum, acid (chemical)
Edema, cornea, due to vitreous touch following surgery (epithelial)
Episcleritis (acute) (chronic) (subacute)
Foreign body, sclera NOS (metallic)
Ectasia, scleral NOS (acquired);
Sclerectasia NOS (acquired);
Staphyloma, sclera NOS (acquired)
Blue spots, sclera (coloration);
Melanosis, sclera (benign) (oculi~
Melanotic lesion, sclerq
Pigmentation,sclera






































165 12.4 0.1 0.1 0.1
1 0.1 0.1
1 0.0 0.0
7 1.2 - 0.1
1 0.0 - 0.0
9 0.8 0.0 0.0
































Rates per 1,000 population
Disease, sclera, type specified NE~
Icterus (conjunctival) (sclera);
Jaundice (conjunctival) (sclera)
Plaque, sclera, calcified (lateral rectus insertion);
Plaque, sclera, (hygiene) (senile)
Thinning, sclera (localized);
Translucent areas, scler~
Yellow (tint), conjunctival or sclera
69. ANTERIOR CHAMBER AND INTRAOCULAR PFIESSURE
Recession, angle, anterior chamber (traumatic);
Trauma, anterior chamber NEC or NOS
Glaucoma, congenital NOS
Flat anterior chamber NOS (with cornea/iris apposition or touch);
Narrow anterior chamber NOS
Shallow anterior NOS (with cornea/iris apposition or touch)
Shallow anterior chamber, due to cataract
Glaucoma NOS
Surgery, glaucoma (post op)
Glaucoma, open angle (chronic) (primary);
Glaucoma, wide angle (chronic) (primary);
Glaucoma, simple or simplex (chronic) (primary)
Glaucoma, simple (surgery)
Glaucoma, narrow angle (primary);
Glaucoma, angle closure (primary);
Glaucoma, closed angle (primary)
Glaucoma, narrow or closed angle (surgery)
Glaucoma, closed angle, secondary
Glaucoma, wide angle, secondaty
Glaucoma, narrow angle, seconda~
Glaucoma, secondary NE~










Glaucoma suspect, narrow anglq
Glaucoma suspect, angle closure;
Narrow angle, grade O, 1, or 11,or occludable;
Shallow angle, grade O, 1, or II
Elevation, intraocular tension--Code only in histo~
Glaucoma suspect NOS
Increase, intraocular tension-Code only in histoty









































































































Cells, anterior chamber (pigment~
Disease, anterior chamber, type specified NEQ
Flare, anterior chamber
70. UVEAL TRACT INFLAMMATION
Inflammation, uveal NOS
Inflammation, uveal, granulomatous
Inflammation, uveal, antenor, active
Inflammation, uveal, anterior, traumatic, active
Inflammation, uveal, anterior, active, granulomatous
Inflammation, uveal, anterior, inactive, granulomatous
Inflammation, uveal, posterior
Inflammation, posterior, infection
Inflammation, uveal, posterior, due to histoplasmoais
Inflammation, posterior, active, granulomatous
Inflammation, uveal, posterior, actiie
inflammation, uveal, posterior, inactive
Inflammation, uveal, posterior, due to syphilis, inactive
Inflammation, uveal, posterior, due to histoplasmosis, inactive
Inflammation, uveal, posterior, due to toxoplasmosis, inactive
(granulomatous);
Scar, chorioretinal, due to toxoplasmosis
71. IRIS AND PUPIL
Pupillary membrane, persistent (congenital);
Pupillary membrane remnant (congenital);
Remnant, pupillaty membrane (congenital);
Remnant, iris, embryologic
Anomaly, congenital, ins and pupil, type specified NEQ
Brushfield spots;
Marcus-Gunn pupil;
Tunics vasculosa Ientis, iris
Incarceration, iris, traumati~
Prolapse, iris, traumatic
Incarceration, ins, following operation. Exclude Incarceration done as
treatment for glaucoma
Iris, adherent to or drawn to wound, following operatio~
Prolapse, iris, following surgery. Used instead of NOS if person has





Tumor, iris, benign. Excludes Neurofibroma
Heterochromia (iridis)
Atrophy, ins NOS (marginal) (partial) (segmental) (sphincter) (stromal)


































































2 0.4 0.3 0.3
5 0.4 0.3
47 4.7 - 0.1 0.1
11 1.6 - 0.1

































Rates per 1,000 population
Coloboma, iris, traumatic 1 0.1 0.1
PAS 24 1.4 0.1 0.4
Synechia, posterior 32 1.6 0.1 0.3 0.0
Anisocoria NOS (surgical);
Dilation, dilatation, pupil, unilateral 116 9.6 0.3
Cyst, iriq
Corectopi*
Disease, pupil, lype specified NE~
Disease, iris, tvDe specified NEC;












Sclerosis, choroidal (central areolar) (peripapillary)
Disease, choroid, type specified NEC
pigment pigmentsry changes, choroidal (irregularity) (peripapillary)
74. CRYSTALLINE LENS
Aberration, Ienticuiac
Disease, lens (crystalline) NOS
Cataract, congenital (anterior) (cortical) (hypermature) (immature)
(intumescent) (mature) (nuclear) (polar) (posterior) (subcspsular)
Cataract, congenital, incompletely or partly absorbed following surgery
Mittendorf dot or spot (congenital) (lens);
Opacity, lens, congenital (anterior) (coronary) (cortical) (crystalline)
(embryonal nucleus) (fetal nucleus); (nuclear) (polar) (post. or posterior)
(punctste) (scattered) (sclerosis) (subcapsukw) (suture);
Opacity, lens, Y suture (anterior);
Opacity, lens, sutural
Cataractj traumatic NOS (anterior) (cortical) (foreign body) (hypermature)
(immature) (intumescent) (mature) (nuclear) (polar) (posterior) (subcapsular)
Cataract, secondary or remains following surgery
Aphakia, traumatic
Cataract NOS (anterior) (cortical) (hypermature) (immature) (intumescent)
(mature) (nuclear) (polar) (posterior) (snowflake) (stellate) (subcapsular)
Cataract. associated with svstemic disease NOS (anterior) (cortical)













(hyperrnature) (immature) ~ntumescent) (mature)’ (nuclear) ‘(polar) “(posterior)
(subcapsular) 6


















































Cataract, senile (anterior) (cortical) (hypermature) (immature) (intumescent)
(mature) (nuclear) (polar) (posterior) (subcapsular)
Cataractj due to myotonic dystrophy
Aphakia NOS
Cataract, secondafy
Cataracta complicate (anterior) (cortical) (hypermature) (immature)
(intumescent) (mature) (nuclear) (polar) (posterior) (subcapsular);
Cataract, secondary to other eye disease (anterior) (cortical) (hypermature)
(immature) (irttumescent) (mature) (nuclear) (polar) (posterior) (subcapsular]
Cataract, complicated
Dislocation, lens (crystalline) NOS (anterior) (posterior)
Opacity, lens (adult nucleus) (anterior) (cortical) (crystalline) (embryonal
nucleus) (fetal nucleus) (nuclear) (polar) (post. or posterior) (punctate)
(scattered) (sclerosis) (snowflake) (subcapsular);
Spoking, lens (anterior);
Sclerosisj nuclear
Disease, lens (crystalline), type specified NE~
Pigment, lens surface (capsule) (epitheliums) (dust) (granules) (iris) (spicules)







Prolapse, vitreous, following surgery. Used instead of NOS if patient has
aphakia, history of cataract surgery, and NO history of trauma
Vitreous in anterior chamber or pupil, due to surgery (band) (degenerated).
Used instead of NOS if person has aphakia, history of cataract surgery,
and NO history of trauma
Vitreous adherent to or against cornea, due to surgery (band). Used instead









Opacity, vitreous (glass-like) (hemorrhage, due to) (myopic) (retrolental)
(vitreous degeneration, due to)
76. RETINA
Arterial sclerosis, retina (grade 1, 2, 3, or 4) (vessel);
Arteriosclerotic vascular disease, retina
Arteriosclerotic retinopathy (grade 1, 2, 3, or 4);
Arteriosclerotic changes, retina (grade 1, 2, 3, or 4) (vessel);
Arteriosclerosis, retina (grade 1, 2, 3, or 4) (vessel}
Arterioiosclerotic retinopathy (grade 1, 2, 3, or 4);





















































































Rates per 1,000 population
Arteriolosclerosis, retina (grade 1, 2, 3, or 4) (vessel);
Arteriolar sclerosis, retina (grade 1, 2, 3, or 4) vessel);
Cholesterol plaque, retinal vessel%
Changes, retinal vessels (grade 1, 2, 3, or 4);
Changes, paramacula~
Dilation, Dilatation, retinal veins
Dilation, Dilatation, retinal capillary
Disease, retina NOS
Edema, retina;
Exudates, retina (cotton wool) (drusen-like) (hard) (waxy);
Generalized narrowing, retinal arteries;
Hemorrhage, retina (blot) (deep) (flame-shaped) (preretinal) (superficial);
Lesion, paramacula~
Microaneu~sms, retina NOS (macula);




Retinopathy, arteriosclerotic (grade 1, 2, 3, or 4);




Tortuosity, retinal vessels (arteries) (veins);
Vitreoreti_nal interface chang~
Venous engorgement, retina
“Other” checked, not described,
“Other” checked, not described,
“Other” checked, not described,
“Other” checked, not described,













Nicking, arteriovenous, retina, hypertensive
Retinopathy, hypertensive











Degeneration, retina NOS (peripapillary)
Cyst, macula
Degeneration, macular (retina) (circinate) (disciform) (pigmentary);
Hole, macula NOS (retina)
Degeneration, macular (retina) traumatic (pigmentary)

























































Occlusion, retinal vessel NOS
Occlusion, retinal artery, central
Occlusion, retinal artery, central, traumatic
Occlusion, retinal artery, branch
Occlusion, retinal vein, central
Occlusion, retinal vein, branch
Detachment, retina NOS
Detachment, retina NOS (Post. Op.)
Atrophy, pigment epithelial (retina~
Freckle, retina
Hyperplasia, pigment epithelial (retina);
Hypopigmentation, retina
pigment, Pigmentation, adjacent to disc (areas);













Pijment, pi~mentary changes, retina (atrophy) ‘(clumping) (depigmentation)
(epithelial) (focal) (freckle) (hyperplasia) (hypopigmentation) (lesion) (mottling)
(peripapillary) (spot);
Salt and pepper fundus 88




Pigment, Pigmentary changes, macula (accumulation) (atrophy) (clumping)
(clumps) (depigmentation) (derangement) (cfkpersion) (disturbance)
(epithelial) (fine) (hyperpigmentation) (irregularity) (mottling) (scattered)
(stippiing~
Stippling, macular (pigment) (pigmentaty) 48
Atrophy, pigment epithelial, macula, traumatiq
Pigment, Pigmentary changes, macula, traumatic (accumulation) (atrophy) 2
(clumping) (clumps) (derangement) (disturbance) (fine) (irregularity) (mottling)
(scattered) (stippling)
Inflammatory lesion, macular, old;
Scar, macula
Scar, chorioretinal or choroid (inactive) (pigment -ary, -cd);
Scar, retina (inactive) (peripapillary) (pigment-ary, -cd)
Beaten silver appearance, macul~
Disease, macula NEC or NOS
Disease, retina, type specified NEG
Edema, macular NOS;
Hollenhorst plaque, retinx
Refractive body or lesion, macula
77. OPTIC NERVE
Blurred disc margin%


















































12 0.9 0.1 0.2
9 0.3 0.2 0.2
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Ophthalmic disease code
of Total Causingexaminees minor . .
Needing Under


















Dieease, optic nerve NOS
Elevation, optic disc or nerve head
Fibrosis, edge of disc (optic);
Irregular dis~
Peeudopapilledem~




Anomaly, congenital, optic disc or nerve NOS
Anomaly, congenital, optic cfao or nerve, vascular or vessel;,
Anomaly, congenital, optic disc or nerve, type specified NEIQ
Bergmeister’s papilla
Coloboma, disc (congenital) (optic);
Cup, Cupping, disc or nerve head, congenita~
Elliptical disc, congenita~
Glial membrane, in front of disG
Hyaloid vessel, disc (remnant);
Hyalod attery, persistence of, disq
Loop, vascular, disc (congenital) (inferior temporal artery) (c~ptic);
Loop, venous, disc, congenital;
Membrane, epipapillary
Oblique insertion, dis~
Pit, disc (congenital) (optic);
Papilla, Bergmeister’s
Remnant hyaloid, disc (fibrotic) (vessel) (system);
Situs inversus, optis nervfa
Vertically elongated shaped disc (congenital)
Neuritis, retrobulbar NOS
Atrophy, optic (nerve) NOS (temporal)
Atrophy, optic (newe), primaty NOS
Atrophy, optic (nerve), traumatic, primary
Atrophy, optic (nerve), associated with multiple sclerosis (primary);
Atrophy, optic (nerve), associated with demyelinating disease (primary)
Atrophy, optic (nerve), secondary NOS (ischemic)
Atrophy, optic (newe), traumatic, secondary
Colloid bodies, dieq
Drusen, disc (oolloid bodies) (hyalin bodies);
Drusen, optic nerve (colloid bodies) (hyalin bodies);
Hyalin bodies, disc
Cresent, disc NOS--Refec
Oiseeee, optic nerve, type specified NEC
Neovascularization, disc (optic);
Pigment clump, disc (nasal)
78. NEUROMUSCULAR





Rates per 1,000 population




































































Nystsgmus, congenital (horizontal) (jerk) (pendular) (rotary) (vertical)
Marcus-Gunn phenomenon with ptosi~
Marcus-Gunn ptosi~
Ptosis, due to cranial nerve paralysis, congenite~
Ptosis in Mercus-Gunn phenomeno~
Ptosis, congenital
Exotropia, congenital (comitant) (incomitent) (intermittent) (alternating) (with
overaction or underaction of oblique)
Anomaly, congenital, neuromuscular,type specified NEQ
Duanes’s syndrome
Nyategmus, NOS (fixational) (gaze) (horizontal) (jerk) (pendular) (rotary)
(vertical)
Postoperative state, strabismus NOS
Esotropia (accommodative) (acquired) (alternating) (comitent) (hyperopic)
(incomitent) (intermittent) (with overaction or underaotionof oblique}
Turning in of eyes
Postoperativestate, esotropia
Exotropia (acquired) (alternating) (comitent) (fever, due to) (incomitent)
(intermittent)(with overaction or undersction of oblique);
Turning out of eyes
Exotropia, secondary to surgery
Hypertropia (alternating) (comitent) (incomitent) (intermittent) (in left or right
lateral gaze) (vertical)
Hypertropia,due to thyroid disease (in left or right lateral gaze) (vertical)
Hypertropia,due to cranial nerve paralysis, due to aneuiyarn
Bell’s palsy, causing ptosi~
Ptosis, due to Bell’s palsy (acquired);
Ptosis, eenilq
Ptosis, due to cranial nerve paralysis
Ptosis, acquired
Ptosis, due to cerebrovascularaccident (stroke)
Ptosis, secondary to surgery





Paralysis, Paresis, cranial nerve (abduoens) (facial) (ooulomotor)(trochlear)
(third) (fourth) (sixth) (seventh)
Absent light reflex (consensual) (direct~
Disease, neuromuscular,type specified NEC
Postoperativestate, tic douloureu~
Postoperative state, trigeminal neuralgia































































































examinees mmor . .
Needing Under






Rates per 1,000 population






Cyst, site and type not specified (excreto~) (obstructed);
Circulation, impaired, poor, site not specified;
Dtscharge from eyes. Coded only if causative condition is unknown;
Diplopia. Coded only if causative condition is unknown;
Dry eye;
Disease, eye, site and type not specified;





NLP (no light perception). Coded only if cause of vision loss is unknoww
Photophobi-q
Pain, eye, site not specified;




Vision blurred, cloudy, decreased, impaired, nil or poor (associated with
heart attack or pregnancy). Coded only if cause of imparied vision is
unknown;
Weak eye
Amblyopia, due to fever (from infection);
Dyslexia
Pseudotumor cerebri;
Scotoma, due to migraine headache (scintillating);
Water tumor, brain 1 0.4 0.4
Defect, field (visual);
Hemianopia, Hemianopsia 1 0.0 0.0
Defect, field, due to meningioma, sphenoid ridge (visual) 1 0.3 0.3 0.2
Disease, eye, site not specified, type specified NEC
Drusen, site not specified 1 0.0 0.0
Ischemic episodes, transient, affecting vision 1 0.0 0.0 0.2
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Appendix IV. Eye pathology
classifications
To assure uniform application of diagnostic crite-
ria throughout the study, diagnoses were added during
medical review at the National Eye Institute in which
the detail of the eye pathology as recorded by the
examining ophthahnologist was consistent with crite-
ria for the more severe or readily identifiable eye
conditions as given in Newell’s report. ” For such
added diagnoses only, the anatomical site and the type
of disease or injury-the first four digits of the NEI
code-were used. No attempt was made to identify the
etiology of such conditions or to make judgments as to
whether the condition caused decrease in vision or
needed medical treatment.
Of the 8,789 eye conditions diagnosed in the
survey, 3,308-38 percent-were added during the
NEI review. These additional diagnoses tended to be
incomplete etiology was identified for only 760, or
fewer than 14 percent, of the 5,481 eye conditions
diagnosed by the field ophthalmologists. Because of
this, diagnostic data in the detailed tables and text of
this report, including the conversion to the more
widely used and understood Eighth Revision, Interna-
tional Classtication of Diseases, Adapted for Use in
the Um”tedStates (ICDA-8) system, is limited to the
first four digits of the NEI codes.
The following listing shows the 4-digit NEI codes
that have been included in each of the 3-digit ICDA-8
codes for classification of these groups of eye condi-
tions.

























Angioma, fibroma, hemangloma, mole, nevus, papilloma, synngoma benign, tumor-eyelid
(6353)
Hemangiorm, Iipoma, nevus, turnor (benign), cyst, dermoid, dermolipoma-conjunctiva
(6553)
Tumor, dermoid-cornea (6753)
Ephelis, freckle, melanoma (benign), nevus, tumor (benign) iris (7153)
Neurofibroma-iris (7154)
Nevus, tumor (benign)-choroid (7353)
Tuberous sclerosis, tumor (benign) - retina (7653)
Growth-eyelid (6350)
Growth, Iimbus, tumor-eyelid (6750)
Tumor-choroid (7350)
Melanocytoma, tumor-optic nerve, disc (7753)
Albinism-retina (7613)
Xanthelasma-eyelid (6364)
Pale, anemic, other manifestations-conjunctiva (6564)
Bell’s palsy, paralysis of cranial nerve (7890)
Homer’s syndrome (7882)
Conjunctivitis, infection, pink eye, injection-conjunctiva (6520)
Foreign body-conjunctiva (6542)
Blepharitis, granulated, allergy - eyelid (6320)
Biepharitis, seborrheic-eyelid (6321)
Blepharitis, sebaceouq herpes zostec acne rosacea-eyelid (6329)
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Other inflammation of uveal tract 366
Inflammation of optic nerve, retina 367
Inflammation of lacrimal glands, ducts 366
















retina, optic nerve 377
Hordeolum, stye (6330)
Keratitis, infection, allergy-cornea (6720)
Ulcer due to herpes simplex or other infection-cornea (6730)
Cogan’s plaques-sclera (6663)
Neovascularization, rukleosis-iris (7174)
Inflammation NOS -uveal tract (7000)
Inflammation-traumatic, granulomatous-uveal tract (7003)
Inflammation-uveal tract, anterior (7050)
Inflammation, active-uveal tract, anterior (7051)
Inflammation, inactive-uveal tract, anterior (7052)
Inflammation, active, granulomatous-uveal tract anterior (7054)
Inflammation, inactive, granulomatous-uveal tract anterior (7055)
Inflammation-uveal tract, posterior (7060)
Inflammation, active-uveal tract, posterior (7061)
Inflammation, inactive-weal tract, posterior (7062)
Inflammation, inactive or scar, due to toxoplasmosis (7065)
Retinitis, sheathing of retinal vessels-optic nerve (7620)
Papillitis-optic nerve (7721)
Neuritis, retrobulbar (7722)
Obstruction, puncture, stenosis--lacrimal process (6460)
Scleritis (6820)
Episclertis (6825)
Cells, flare, disease (6999)
Hyalitis, opacity (7560)
Myopic changes, atrophy, thinning (6161)
Myopic degeneration, malignant myopia, degeneration of retina (7668)
Opacity due to foreign body, metallic, rust lesion-cornea (6787)
Opacity due to burn-cornea (6788)
Opacity due to infection, old healed ulcer, etc.-cornea (6789)
Pterygium-conjunctiva (6572)
Pterygium, opacity due to removal of pterygium-cornea (6772)
Esophoria, congenital (7813)
Exotropia, congenital (7814)




Cataract, congenital-lens (741 1)
Cataract, congenital, partly absorbed-lens (741 3)
Mittendorf spot, congenital or sutural opacity (7418)
Cataract or aphakia, traumatic (7447)
Cataract, metabolic, diabetic, senile (7460)
Cataract, secondary 1[7463)
Cataract, secondary to other eye disease (7464)












due to systemic disease or NOS (6970)
simple open or wide angle (6972)












Atrophy of iris, traumatic (7144)
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ICDA condition group ICDA code NEI inclusionand code
Other diseases of retina, optic nerve 377 Drusen-choroid, retina, macula (7363)







Degeneration, paving stone-retina (7666)
Degeneration, senile or other peripheral (7667)
Degeneration, retina NOS (7669)





Occlusion retinal vessel NOS (7680)
Occlusion, retinal artery, central (7682)
Occlusion, retinal artery, branch (7683)
Occlusion, retinal vein, central (7685)
Occlusion, retinal vein, branch (7686)





Disease, depigmentation, deterioration-optic nerve (7700)
Papilledema (7760)
Amblyopia (no code)
Atrophy, traumatic or NOS-optic nerve (7761)
Atrophy, primay-optic nerve (7762)
Atrophy, secondaty-optic nerve (7763)
Colloid bodies, drusen-disc (7767)
Conus, disc (7770)
Crescent, neovascularization, pigment clump-disc (7799)
Blindness NOS, cyst, impaired circulation, etc.-site not specified (9900)
Drusen, disease, ischemic episodes affecting vision-site not specified (9999)
Other diseases of eye 378 Miscellaneous conditions of eyelid-keloid, nodule, papule, pigment, etc. (6300)
Postoperative state, chalazion (6331)
Meibomianitis (6333)
Blepharochalasis, dermochalasis, elastosis-eyelids (6360)
Entropion-NOS (6361)




Cyst, disease-lacrimal process (6499)
Disease, trauma, vascularization-conjunctiva (6500)




Opacity due to foreign body, rust Iesion-conjunctiva (6587)
Scar-conjunctiva (6589)
Bitot’s spot, xerosis, disease NOS-conjunctiva (6599)
Phthisis (6662)




Dystrophy, lattice degeneration-cornea (6765)
Dystrophy marginal-cornea (6766)
Dystrophy, posterior, endothelial (6767)
Cornea guttata (6768)
Dystrophy, nodular or granular-cornea (6769)
Cornea tarinata, degeneration NOS (6770)
Dystrophy, senile-cornea (6771)
Keratitis sicca, drying-cornea (6775)
Dry spot, tears deficient-cornea (6776)




Edema, bullous keratitis (6799)
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ICDA condition cvourr ICDA code NEI inclusion and code




Hypertrophic, atrophic, diseases of
skin










Scar, disease, trauma NOS-sclera (6800)
Congenital anomaly, thinning-sclera (6819)
Scleromalacia in rheumatoid arthritis or NOS (6830)
Foreign body-sclera (6842)
Ectasia, staphyloma, etc., acquired or secondary to disease-sclera (6861)
Melanosis, blue spots-sclera (6862)
Icterus, jaundice, plaque, thinning-sclera (6899)
Disease, trauma NOS - anterior chamber (6900)
Schwalbe’s line, congenital anomaly-anterior chamber (6919)
Cyst, down growth - anterior chamber (6944)
Shallow, flat, narrow - anterior chamber (6961)
Bulge, dilation, disease, trauma-iris (71 00)
Papillary membrane, remnant-congenital (71 13)
Incarceration, prolapse-ids (7145)
Tumor, pigmentation N(3S - iris (7150)
Heterochromia - iris (71160)
Atrophy NOS - iris (7161)
Synechia NOS (7171)
Synechia, anterioc PAS (7172)
Synechia, posterioc seclusion-pupil (7173)
Anisocoria, dilation, traumatic mydriasis-pupil (7180)
Iridiplegia (7185)
Miosis, constriction-pupil (71 88)




Aberration, disease, surgery NOS - lens (7400)
Disiocaticm-lens (74?’0)
Pseudoexfoliation-lens (7477)
Disease, surface pigment-lens (7499)





Absent light reflex, etc. (7699)
Anophthalmos, surgical (6601, 6644)
Arteriosclerotic changee-retina (7600)
Rash, pustule, dermatitis-eyelid (6332)
Eczema-eyelid (6335)
Angioma, cafe-au-lait spot, disease, etc. - eyelid (6399)
Congenital anomaly-ortjit (6219)
Asymmetry, disease, herniation of fat-orbit (6299)
Entropion, congenital (6311)





Congenital anomaly-iris, pupil (71 19)
Coloboma (7168)
Congenital anomaly-vitreous (751 9)
Congenital anomaly-retina (761 9)
Retinitis pigmentosa (7675)
Congenital anomaly NU%fisc, optic nerve (771 O)
Congenital anomaly, vascular or other specified type-optic nerve (7719)
Nystagmus, congenital (7811)
Marcus-Gunn, other ptosis (7812)
Duane’s syndrome, other congenital anomaly (7819)





Visual field defect (9970)
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ICDA condition group ICDA code NEI inclusion and code
Fracture, skull 802 Fracture, implant-orbit (6244)
Open wound—eye, orbit 870 Prolapse, traumatic-vitreous (7544)
Vitreous attached to cataract incision or wound (7545)
Contusion – eye orbit 921 Abrasion, contusion, erosion-eyelid (6340)
Trauma, excessive tearing, dieease - Lacrimal (6400)
Abrasion, edema, keratitis - cornea (6740)
Bloodstaining - cornea (6745)
Disease, trauma-choroid (7300)
Foreign body—eye 930 Foreign body-eyelid (6342)
Foreign body-cornea (6742)
Foreign body-iris (7142)




Age.—The age recorded for each examinee was the
age at last birthday at the time of examination. The age
criterion for inclusion in the sample used in this survey
was defined as age at time of census interview. In this
sample there were a few examinees who were 74 years
of age at the time of interview but 75 years of age at
examination. In the adjustment and weighting proce-
dures used to produce national estimates, these persons
were included in the 74-years group.
Race.—Race was recorded as “white,” “black,” or
“other.” “Other” included Japanese, Chinese, Ameri-
can Indian, Korean, Eskimo, and all races other than
white and black. Mexicans were recorded as white
unless definitely known to be American Indian or of
other nonwhite race. Blacks and persons of mixed
black and other parentage were recorded as black.
When persons of mixed racial background were
uncertain about their race, the father’s race was
recorded.
Geographic region.—The 48 contiguous States and
the District of Columbia (excluding Alaska and
Hawaii) were stratified into 4 broad geographic regions
of about equal population. With a few exceptions, the
compositions of the regions were as follows:
Region States included
Northeast . . . . . . . . . . Maine, New Hampshire, Vermont, Massa-
chusetts, Connecticut, Rhode Island,
New York, New Jersey, Pennsylvania
Midwest . . . . . . . . . . . . Ohio, Michigan, Indiana, Illinois, Wis-
consin, Minnesota, Iowa, Missouri
South . . . . . . . . . . . . . . . Delaware, Maryland, Virginia, West Vir-
ginia, Kentucky, Arkansas, Tennessee,
North Carolina, South Carolina, Georgia,
Florida, Alabama, Mississippi, Louisiana,
District of Columbia
West . . . . . . . . . . . . . . . Washington, Oregon, Idaho, Montana,
Wyoming, Colorado, Utah, Nevada, Cali-
fornia, Arizona, New Mexico, Texas, Okla-
homa, Kansas, Nebraska, South Dakota,
North Dakota
In a few instances the actual boundaries of the
regions do not follow State lines. Some strata in the
Midwest and South include PSU’S actually located in
the West. Similarly, some strata in the West contain
PSU’S located in the Midwest and South.
Urban-rural.—The classification of urban-rural
areas is that used in the 1960 census. According to the
1960 definition, those areas considered urban are: (1)
places of 2,500 inhabitants or more incorporated as
cities, boroughs, villages, and towns (except towns in
New England, New York, and Wisconsin); (2) the
densely settled urban fringe, whether incorporated or
unincorporated, of urbanized areas; (3) towns in New
England and townships in New Jersey and Pennsylva-
nia that contain no incorporated municipalities as
subdivisions and have either 2,500 inhabitants or
more, or a population of 2,500 to 25,000 and a density
of 1,500 persons per square mile; (4) counties in States
other than the New England States, New Jersey, and
Pennsylvania that have no incorporated municipalities
within their boundaries and have a density of 1,500
persons or more per square mikq and (5) unincorporat-
ed places of 2,500 inhabitants or more that are not
included in any urban fringe. The remaining popula-
tion is classified as rural.
By means of the first digit of the identification code
on the household questionnaire, the urban and rural
population is divided into the following categories
according to population: (1) urban, 3,000,000 or mor%
(2) urban, 1,000,000-2,999,999; (3) urban,
250,000-999,999; (4) urban, under 250,00Q (5) urban
not in urbanized areas, 25,000 or more; (6) urban not
in urbanized area, 10,000-24,999; (7) urban not in
urbanized area, 2,500-9,999; and (8) rural.
Family income.—The income recorded is the total
income received during the 12 months prior to the
interview by the head of the household and all other
household members related to the head. This income is
the gross cash income (excluding pay in kind) except
in the case of a family with its own farm or business. In
that instance net income is recorded. Also included is
the income of a member of the Armed Forces living at
home with his family (even though he is not consid-
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ered a household member). If he is not living at home,
allotments and other money received by ;he family
from him are included in the family income figure.
Education. —The only grades counted are those
that have been attended in a “regular” school where
persons are given formal education-either graded
public or private schools, day or night, full-time or
part-time attendance. A regular school is one that
advances a person toward an elementary certificate or
high school diploma or a college, university, or
professional school degree. Education received in
vocational, trade, or business schools outside the
regular school system is not counted in determining
the highest grade of school completed. If a person
attended school in a foreign country, at an upgraded
school, under a tutor, or under other special circum-
stances, the nearest equivalent of his highest grade
attended is assigned.
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Programs and Collection Procedures. -Reports describing
the general programs of the National Center for Health
Statistics and its offices and divisions and the data col-
lection methods used. They also include definitions and
other material necessary forunderstanding the data.
Data Evaluation and Methods Research. -Studies of new
statistical methodology including experimental tests of
new survey methods, studies of vital statistics collection
methods, new analytical techniques, objective evaluations
of reliability of collected data, and contributions to sta-
tistical theory.
Analytical and Epidemiological Studies. -Reports pre-
senting analytical or interpretive studies based on vital
and health statistics, cerrying the analysis further than the
expository types of reports inthe other series.
Documents and Committee Reports. -Final reports of
major committees concerned with vital and health sta-
tistics and documents such as recommended model vital
registration laws and revised birth and death certificates.
Data from the National Health Interview Survey. -Statis-
tics on illness, accidental injuries, disability, use of hos-
pital, medical, dental, and other services, and other
health-related topics, all based on data collected in the
continuing national household interview survey.
Data From the National Health Examination Survey and
the National Health and Nutrition Examination Srrrvey.–
Data from direct examination, testing, and measurement
of national samples of the civilian noninstitutionalized
population provide the basis for (1) estimates of the
medically defined prevalence of specific diseases in the
United States and the distributions of the population with
respect to physical, physiological, and psychological
characteristics and (2) analysis of relationships among the
various measurements without reference to an explicit
finite universe of persons.
Data From the Institutionalized Population Surveys. -Dis-
continued in 1975. Reports from these surveys are in-
cludad in Series 13.
Data on Health Resources Utilization. -Statistics on the







long-term care, ambulatory care, hospital care, and family
planning services.
Data on Health Resources: Manpower and Facilitias.-
Statistics on the numbers, geographic distribution, and
characteristics of health resources including physicians,
dentists, nurses, other health occupations, hospitals,
nursing homes, and outpatient facilities.
Data From Special Surveys. -Statistics on health and
health-related topics collected in special surveys that are
not a part of the continuing data systems of the National
Center for Health Statistics.
Data on Mortality .–Various statistics on mortality other
than as included in regular annual or monthly reports.
Special analyses by cause of death, age, and other demo-
graphic variables; geographic and time series analyses; and
statistics on characteristics of deaths not available from
the vital records based ensample surveys of those records.
Data on Natality, Marriage, and Divorce.–Various sta-
tistics on natality, marriage, and divorce other than as
included in regular annual or monthly reports. Special
analyses by demographic variables; geographic and time
series analyses; studies of fertility; and statistics on
characteristics of births not available from the vital
records based ensample surveys of those records.
Data From the National Mortality and Natality Surveys.–
Discontinued in 1975. Reports from these sample suweys
based on vitaI records are included in Series 20 and 21,
respectively.
Data From the National Suwey of Family Growth.–
Statistics on fertility, family formation and dissolution,
family planning, and related maternal and infant health
topics derived from a periodic survey of a nationwide
probability sample of ever-married women 1544 years of
age.
For a list of titles of reports published in these series, write to:
Scientific and Technical Information Branch
National Center for Health Statistics
Public Health Service
Hyattsville, Md. “20782
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